















































epilepsy,	where	 there	 is	excessive	or	synchronized	 firing	 in	 the	brain.	 	There	 is	




excitability	and	seizure	susceptibility	due	to	 its	 large	repertoire	of	genetic	 tools	






display	 a	 robust	 seizure	 phenotype	 in	 response	 to	 a	 mechanical	 or	 electrical	
stimulus	and	we	used	the	weakly	semi‐dominant	BS	mutant,	slamdance	(sda)	as	
the	 sensitized	background	 to	 screen	with	 a	 set	 of	 deficiency	mutants	 that	 span	
over	 chromosome	 3R.	 	 Through	 this	 screen,	 we	 found	 10	 candidate	 seizure	
enhancer	 genes,	 8	 of	 which	 have	 not	 been	 previously	 linked	 to	 a	 neuronal	
excitability	phenotype.		We	further	analyzed	pumilio	(pum),	one	of	the	enhancers	
 found	 in	 this	 screen.	 	pum	 encodes	 a	 translational	 repressor	 involved	 in	many	
processes	in	Drosophila	development,	from	larval	body	axis	patterning	to	roles	in	




cholinergic	 and	GABAergic	 neurons,	 to	 regulate	neuronal	 excitability	 and	 affect	
seizure	 susceptibility.	 	We	 further	 determined	 that	 Pum	expression	 is	 required	





Hannah	 was	 born	 in	 Los	 Angeles,	 California	 and	 grew	 up	 in	 Monterey	 Park,	
California	all	of	her	life,	except	for	two	years	where	she	lived	on	the	opposite	side	
of	 the	nation	 in	Augusta,	Georgia	between	 the	ages	of	 seven	 to	nine.	 	Once	 she	
returned	to	Monterey	Park,	she	attended	Monterey	Highlands	Elementary	School,	
which	had	a	surprising	number	of	exciting	and	adventurous	science	teachers	that	
encouraged	Hannah’s	 curiosity	 of	 the	 natural	world	with	 activities	 that	 ranged	







the	 Young	 Engineering	 and	 Science	 Scholars	 at	 the	 California	 Institute	 of	
Technology	 (Caltech)	 where	 she	 spent	 a	 month	 of	 intense	 science	 exploration	
with	 a	 group	 of	 like‐minded	 high	 school	 students	 from	 which	 she	 emerged	
knowing	that	science	was	going	to	be	a	part	of	her	future.		She	liked	the	summer	
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firing	 in	 the	brain,	 sometimes	 resulting	 in	 seizure,	 or	 even	epilepsy.	 	There	are	
numerous	 conditions	 that	 can	 lead	 to	 seizures,	 such	 as	 head	 injuries,	 medical	
conditions,	 stroke,	 and	 mutations	 in	 genes.	 	 The	 genetics	 behind	 seizure	 and	







the	 brain.	 	 This	 activity	 can	manifest	 outwardly	 in	 a	 wide	 range	 of	 behaviors,	
from	 a	 short	 loss	 of	 awareness	 (absence	 seizure),	 to	 convulsions	 of	 the	 entire	
body	 (tonic‐clonic	 seizure).	 	The	seizures	can	be	 limited	 to	 specific	parts	of	 the	
brain	 in	 cases	 of	 partial	 seizure,	 or	 they	 can	 spread	 through	 the	 entire	 brain,	
which	is	known	as	a	generalized	seizure.		Epilepsy	occurs	when	seizures	become	











discover	mutations	 that	 caused	 epilepsies	 in	 families,	 using	 techniques	 such	 as	
pedigree	analysis	and	linkage	mapping.		In	many	of	these	cases,	the	mutated	gene	
turned	out	to	encode	defective	ion	channels	or	channelopathies,	such	as	SCN1A,	
which	 encodes	 a	 subunit	 of	 the	 voltage	 gated	 sodium	 channel,	 KCNQ2,	 which	
encodes	 a	 delayed	 rectifier	 	 potassium	 channel,	 and	GABRG2,	 which	 encodes	 a	
gamma‐aminobutyric	acid	(GABA)	receptor	subunit	(reviewed	in	[4–6]).			
	
More	recently,	newer	 techniques	have	been	used	 to	 identify	genes	 that	had	not	
previously	 been	 known	 to	 be	 involved	 in	 epilepsy	 and	 do	 not	 encode	 ion	
channels.		One	example	of	this	is	the	gene	STXBP1,	a	conserved	gene	also	known	
as	MUNC18	and	Sec1,	which	causes	early	infantile	epileptic	encephalopathy.		This	
gene	 was	 identified	 from	 a	 single	 patient	 using	 comparative	 genomic	
hybridization.	 	 Unlike	 the	 previously	 identified	 channelopathies,	 this	 gene	
product	 is	 involved	 in	 the	 release	 of	 synaptic	 vesicles	 [7].	 	 A	 genome‐wide	
association	study	was	also	performed	 in	order	 to	 find	candidate	epilepsy	genes	
among	 cases	 of	 partial‐onset	 epilepsy,	 though	 this	 did	 not	 produce	 any	 clear	
candidate	genes	[8].	 	Other	recent	studies	identified	potential	epilepsy	genes	by	
using	 an	 oligonucleotide	 assay	 to	 identify	 copy	 number	 variants	 in	 cases	 of	
idiopathic	epilepsy	[9].		It	is	suggested	that	as	the	field	of	epilepsy	genetics	moves	













The	 search	 for	 genes	 underlying	 epilepsy	 is	 often	 limited	 by	 needing	 large	
numbers	of	people	affected	by	the	same	type	of	epilepsy	and	having	to	work	with	
epilepsies	 already	 in	 existence.	 	 Animal	 models	 offer	 many	 other	 methods	 of	
searching	 for	 novel	 genes	 underlying	 neuronal	 excitability,	 especially	 with	
respect	 to	 genes	 that	 may	 contribute	 to	 susceptibility	 to	 seizures	 though	 they	
cause	no	apparent	seizure	phenotype	on	their	own.	
		
Small	mammals,	 especially	mice	 and	 rats,	 have	 long	 been	 used	 as	 a	model	 for	
epileptogenesis	 and	 epilepsy,	 most	 commonly	 through	 either	 electrically	 or	
chemically	 induced	 seizures.	 	 One	 well‐known	 model	 is	 the	 classical	 kindling	
model,	where	 repeated	 seizures	 are	 induced	by	 chemical	 or	 electrical	 stimulus.	
This	 method	 added	 to	 knowledge	 about	 changes	 in	 behavior	 after	 recurrent	
seizures.	 	There	are	other	models	of	 recurrent	 spontaneous	seizures	 that	begin	
with	 exposure	 to	 convulsants	 such	 as	 pilocarpine	 or	 kainate.	 	 There	 have	 also	
been	 studies	 of	 genetic	 and	 transgenic	 mouse	 seizure	mutants	 that	 have	 been	
used	to	model	specific	types	of	epilepsy	(reviewed	in	[10],	[11]).			
	
More	 recently,	 zebrafish	 studies	 have	 made	 progress	 in	 epilepsy	 research.		
Zebrafish	 have	 been	 used	 in	 anti‐epileptic	 drug	 screening	 to	 test	 responses	 to	
chemically	 induced	 seizures	 while	 recording	 brain	 responses	 using	
electroencephalograms.	 	There	are	also	genetic	 zebrafish	epilepsy	models,	 such	











to	 use	 for	 epilepsy	 studies.	 	 Flies	 exhibit	 a	 number	 of	 interesting	 behaviors,	
including	 various	 seizure	 and	 paralytic	 phenotypes.	 	 Their	 short	 lifespans	 and	
small	 size	 make	 it	 possible	 to	 screen	 large	 numbers	 of	 flies	 quickly.	 	 The	
availability	 of	 genetic	 tools	 also	 allow	 for	 in‐depth	 analysis	 of	 individual	 genes	
and	interactions	between	them.		Work	in	Drosophila	has	made	many	advances	in	
characterizing	seizure	mutants	and	developing	techniques	that	allow	us	to	learn	




Near	 the	 start	 of	 research	 into	 the	 study	 of	 neurogenetics	 in	Drosophila,	many	
behavioral	 mutants	 were	 collected	 in	 order	 to	 learn	 more	 about	 altered	
membrane	physiology,	often	 through	changes	 in	 ion	channel	 function.	 	 Some	of	
the	 earliest	 known	 behavioral	 mutants	 that	 displayed	 seizure	 or	 paralysis	
phenotypes	were	indeed	ion	channel	mutants.		For	example,	three	mutants	were	
discovered	 that	 had	 leg‐shaking	behavior	 upon	 exposure	 to	 ether.	 	 These	were	
named	Shaker	 (Sh),	ether‐a‐go‐go	 (eag),	 and	Hyperkinetic	 (Hk).	 	The	underlying	
cause	of	the	phenotype	was	discovered	to	be	defects	in	potassium	ion	channels.		
Likewise,	 three	 temperature‐sensitive	 paralytic	 mutants,	 temperature‐induced	




compared	 to	 the	 leg‐shaking	 and	 temperature	 sensitive	 mutants.	 	 Though	
 5 
phenotypically	 normal	 in	most	 circumstances,	 they	 respond	 to	 stimuli	 such	 as	
mechanical	 impact	 or	 electrical	 stimulus	 with	 a	 robust	 seizure	 and	 paralysis	
phenotype	[13–15].		To	date,	there	are	14	bang‐sensitive	mutants	that	represent	
12	different	 genes	 [16].	 	One	of	 the	 confusing	aspects	of	 these	BS	mutants	was	
that	 the	 genes	 underlying	 these	 mutations	 code	 for	 a	 wide	 variety	 of	 gene	
products	 that	do	not	have	obvious	 connections	despite	 their	 similar	behavioral	
phenotypes.	 	For	example,	 the	products	of	 the	genes	affected	 in	the	BS	mutants	
technical	 knockout	 (tko),	 kazachoc	 (kcc),	 and	 couch	 potato	 (cpo)	 are	 a	
mitochondrial	 ribosomal	 protein,	 citrate	 synthase,	 and	 RNA‐binding	 protein,	
respectively	[17–19].		easily	shocked	(eas)	is	a	robust	recessive	BS	mutant	that	is	
defective	 in	 an	 ethanolamine	 kinase,	 resulting	 in	 an	 altered	 membrane	
phosopholipid	 composition	 [20].	 	 slamdance	 (sda)	 mutants	 have	 a	 defect	 in	
aminopeptidase	 N,	 which	 leads	 to	 an	 increased	 persistent	 sodium	 current	 in	
motoneurons,	 which	 suggests	 an	 increased	 excitability	 of	 the	 motor	 system.		
Electrophysiological	 and	 pharmacological	 tests	 indicate	 that	 the	 sda	 seizure	
phenotype	may	arise	from	defects	 in	neural	development	[21],	[22].	 	One	of	the	
most	robust	and	difficult	to	suppress	BS	mutation	is	paralyticbangsenseless1	(parabss1)	
which	 has	 been	 essential	 in	 developing	 a	 Drosophila	 model	 for	 seizure	 and	
epilepsy	[23],	[24].	 	Though	this	mutant	was	used	as	a	model	for	seizure	in	flies	
for	many	years	due	to	its	tonic‐clonic‐like	seizures,	it	was	not	until	recently	that	
parabss1	 mutation	 was	 confirmed	 to	 be	 a	 gain‐of‐function	 allele	 of	 the	 sodium	
channel	gene	encoded	by	para.		This	gain‐of‐function	mutation	results	in	a	defect	
of	 sodium	 channel	 inactivation	 [25].	 	 It	 is	 also	 interesting	 to	 note	 that	 loss‐of‐
function	mutations	in	para	are	very	effective	seizure	suppressors	[24].	
	




followed	 by	 a	 period	 of	 paralysis	 where	 the	 flies	 are	 unresponsive	 to	 any	
 6 
mechanical	or	electrical	stimulus.	 	Finally,	the	flies	have	a	brief	recovery	seizure	
similar	 to	 the	 initial	 seizure	 [26].	 	 parabss1	 mutants	 deviate	 slightly	 from	 this	
pattern	 in	 that	 there	 is	 a	 tonic‐clonic	 phase	 in	 between	 the	 period	 of	 paralysis	
and	the	recovery	seizure	[25].		Heterozygous	BS	mutants	for	the	most	part	do	not	
show	 BS	 behavior,	 except	 in	 the	 case	 of	 sda	 and	 parabss1,	 which	 are	 semi‐
dominant.	 	 The	 penetrance	 of	 seizure	 is	 lowered	 greatly	 in	 sda	 heterozygotes,	
while	parabss1	heterozygotes	have	higher	penetrance.	 	If	seizure	is	initiated	after	
the	stimulus,	these	heterozygotes	show	typical	BS	seizures.		In	the	case	of	parabss1	




or‐none	 behavior	 that	 can	 be	 only	 quantified	 by	 the	 penetrance	 of	 the	 BS	
phenotype,	 which	 is	 very	 high	 in	 homozygous	 BS	 mutants.	 In	 order	 to	 obtain	
more	quantitative	measurements	of	the	change	in	seizure	threshold	in	various	BS	
mutants,	 a	 method	 of	 delivering	 electrical	 stimuli	 directly	 to	 the	 brain	 and	
eliciting	 seizure	 through	 the	 giant	 fiber	 (GF)	 pathway,	which	 is	 responsible	 for	
the	fly	escape	response,	was	developed.		The	activation	of	the	GF	pathway	due	to	
the	 electrical	 stimulus	 caused	 trains	 of	 seizure‐like	 activity	 in	 the	 dorsal	
longitudinal	muscles	(DLM)	of	the	flight	muscles	in	BS	animals	[20].	 	During	the	
paralysis	phase	of	 the	seizure,	 there	was	a	corresponding	 failure	of	 the	DLM	to	
respond	to	any	stimulation	of	the	GF	pathway	[15].	Using	this	method,	the	seizure	





With	 the	 availability	 of	 behavioral	 and	 electrophysiological	 techniques	 to	
quantify	 the	 seizure	 susceptibility	 of	 BS	 mutants,	 screens	 for	 possible	 genetic	





novel	 targets	 for	 testing	 anti‐epileptic	 and	 anti‐convulsant	 drugs.	 	 In	 general,	
most	of	the	discovered	genes	have	been	suppressors	of	BS	mutations.	
	
Some	 of	 the	 first	 experiments	 in	 this	 area	 observed	 the	 effects	 on	 different	
seizure	and	paralysis	mutants	in	combination	with	each	other.	 	Therefore,	these	
tests	started	with	two	behavioral	mutants.	 	Several	of	the	temperature‐sensitive	
paralytic	 mutants,	 such	 as	 napts	 and	 para,	 were	 able	 to	 successfully	 suppress	
bang‐sensitive	seizures	[26],	[28].			
	
Often	 a	 reverse	 genetics	 approach	 was	 taken	 in	 order	 to	 find	 enhancers	 and	
suppressors	 of	 bang‐sensitivity.	 	Genes	known	 to	 affect	 neuronal	 excitability	 in	
other	 organisms	 are	 then	 tested	 in	 Drosophila	 to	 see	 their	 effects	 on	 seizure	
behavior.		One	example	of	this	is	the	study	of	shakB2.		Previous	work	showed	that	
mouse	 mutants	 of	 a	 specific	 connexin,	 or	 gap	 junction	 protein,	 had	 weakened	
epileptoform	 discharges	 in	 hippocampal	 slices	 [29].	 	 Because	 of	 this	 result,	






in	 seizure	 susceptibility.	 	 For	 example,	 in	 a	 screen	 for	 gain‐of‐function	 seizure	
suppressors	 of	 eas,	 the	 gene	 escargot	 (esg)	 was	 identified	 multiple	 times	 as	 a	
seizure	 suppressor,	 among	 several	 other	 genes.	 	 esg	 is	 particularly	 of	 interest	
because	it	 is	 involved	in	neural	development	and	is	able	to	suppress	seizures	in	
multiple	 BS	 mutants	 [31].	 	 In	 another	 suppressor	 screen	 using	 P	 element	
mutagenesis	 in	 the	 eas	 background,	 the	 gene	 topoisomerase	 I	 (top1JS)	 was	
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discovered	 to	 be	 a	 BS	 suppressor.	 	 This	 gene	 also	 had	 not	 been	 previously	
implicated	 in	 seizure	 susceptibility	 and	 is	 involved	 in	Drosophila	 	 development	





to	 screen	 through	 many	 flies	 relatively	 quickly	 and	 without	 using	 excessive	
resources,	 such	 as	 in	mutagenesis	 screens.	 	With	 the	 availability	of	 fly	mutants	
that	either	cause	seizure	behavior	or	can	suppress	seizure	behavior,	screening	for	
new	 anti‐epileptic	 drugs	 in	 Drosophila	 becomes	 possible.	 	 Discovery	 of	 anti‐
epileptic	 drugs	 affecting	 BS	 mutants	 can	 also	 help	 reveal	 the	 mechanisms	
underlying	the	bang‐sensitive	phenotype,	which	is	not	well	understood.			
	





BS	 seizures	 [30],	 [33–36].	 	 Some	 of	 the	 effects	 of	 these	 drugs	 include	 faster	
recovery	from	paralysis,	or	suppression	of	tonic‐clonic	behavior	in	parabss1	[32].	
	











model	 for	 epilepsy	 were	 reviewed.	 	 While	 many	 aspects	 of	Drosophila	 seizure	
susceptibility	have	been	studied,	such	as	the	behavior	of	bang‐sensitive	mutants,	
the	 genes	 underlying	 these	 behaviors,	 and	 the	 ability	 of	 anti‐epileptic	 drugs	 to	
suppress	 BS	 behavior,	 one	 area	where	 there	 has	 not	 been	much	 study	 are	 the	
genes	 responsible	 for	 seizure	 susceptibility,	 which	 can	 cause	 genetic	
predisposition	for	eventual	epileptogenesis.		In	chapter	2,	a	screen	for	enhancers	
of	the	BS	mutant	sda	is	described,	along	with	eleven	candidate	genes	that	may	be	
enhancers	 of	 seizure	 susceptibility.	 In	 chapter	 3,	 analysis	 of	 a	 gene,	 pumilio,	
which	was	found	through	this	screen	is	described.		This	work	is	then	summarized	
and	 discussed	 in	 chapter	 4.	 	 Appendix	 A	 summarizes	 the	 results	 of	 the	






























































































































DEFICIENCY SCREEN FOR ENHANCERS OF THE BANG-SENSITIVE 
MUTANT SLAMDANCE 
 
2.1  Abstract 





finding	 genes	 that	 enhance	 neuronal	 excitability	 in	 flies	 using	 a	 sensitized	
seizure‐susceptible	 background.	 	 Bang‐sensitive	 (BS)	 mutants,	 in	 particular,	
display	a	robust	seizure	phenotype	after	a	mechanical	stimulus,	and	a	subset	of	
these	 mutants	 are	 semi‐dominant	 and	 the	 seizure	 phenotype	 is	 only	 partially	
penetrant	 in	 heterozygous	 animals,	 allowing	 us	 to	 screen	 for	 enhancers	 that	
increase	 the	 severity	 or	 penetrance	 of	 the	 phenotype.	 	 Using	 the	 BS	 mutant	
slamdance	(sda),	I	performed	a	deficiency	screen	with	the	Exelixis	3R	deficiency	





susceptibility,	 8	 of	 which	 have	 not	 previously	 been	 described	 to	 cause	 this	
phenotype.	
 
2.2  Introduction 
Epilepsy,	 a	 seizure	 disorder	 characterized	 by	multiple	 unprovoked	 seizures,	 is	
extremely	prevalent	 in	 the	world	 today.	 	 It	affects	1%	of	 the	overall	population	
and	 is	 experienced	 by	 3%	 of	 the	 population	 at	 some	 point	 in	 their	 lives	 [1].		
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small	 percentage	 of	 these	 genetically‐based	 epilepsies.	 	 Known	 epilepsy‐
associated	genes	 that	encode	 ion	channels	 in	neurons,	where	mutations	 lead	 to	





In	 order	 to	 obtain	 a	 better	 understanding	 of	 known	 epilepsy	 genes,	 as	well	 as	
discover	 new	 ones,	 we	 need	 to	 turn	 to	 model	 systems.	 	 Animal	 models,	 from	
insects	 to	primates,	have	been	useful	 in	 learning	about	epileptogenesis,	 such	as	
through	mouse	models	of	electrical	kindling	or	chemically	induced	seizures	using	
convulsants	 [2],	 [4].	 	 Certain	models	 are	 also	 important	 for	 anti‐epileptic	 drug	





determining	 gene	 function	 in	 vivo.	 	 Their	 short	 lifespans	 and	 a	 more	 compact	
genome	 with	 single	 copies	 of	 genes	 that	 may	 be	 found	 as	 multiples	 in	 a	
mammalian	 genome	 are	 two	 important	 features	 of	 this	 model	 system.	 	 The	
availability	of	well‐developed	genetic	tools	is	also	advantageous	for	screening	or	
genetic	 manipulation.	 	 While	 this	 system	 has	 been	 essential	 in	 studying	 many	
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different	 biological	 processes,	 one	 concern	 may	 be	 that	 flies	 are	 not	 the	 ideal	





of	 existing	 seizure	 mutants,	 screening	 for	 genetic	 seizure	 suppressors,	 and	
searching	 for	 seizure‐suppressing	 chemicals	 and	 drugs	 [6].	 	 For	 example,	
electrical	stimuli	to	fly	brains	can	induce	seizure‐like	behavior	[7],	[8].		Also,	anti‐
epileptic	 drugs	 such	 as	 valproate	 [9],	 phenytoin,	 gabapentin	 [10],	 potassium	
bromide	 [11],	 and	 levetiracetam	 (Ronald	 Hoy	 and	 David	 Deitcher,	 personal	
communication)	have	been	found	to	suppress	seizure	behaviors	in	flies.	
	
Drosophila	 seizure	 mutants	 have	 altered	 neuronal	 excitability	 compared	 to	
normal	 flies	 and	 exist	 in	 several	 main	 categories:	 leg‐shakers,	 temperature	
sensitives,	and	bang‐sensitives	[12].	 	The	Drosophila	bang‐sensitive	(BS)	mutant	
class	 contains	 14	 alleles	 of	 12	 genes	 [6].	 	 Some	 of	 these	 mutants,	 such	 as	
paralyticbangsenseless1	 (parabss1)	 and	 slamdance	 (sda),	 are	 semi‐dominant	 in	 the	
heterozygous	 state	 [7].	 	parabss1	 is	 considered	 to	 be	 one	 of	 the	 strongest	 bang‐
sensitive	 mutants,	 and	 the	 electrical	 activity	 in	 the	 brain	 during	 the	 seizure	
behavior	is	likened	to	tonic‐clonic	seizures.	 	It	 is	known	to	be	a	gain‐of‐function	
allele	 of	 the	 paralytic	 voltage‐gated	 Na+	 channel	 [13].	 	 Another	 bang‐sensitive	
mutant,	 sda,	 has	a	weaker	 seizure	phenotype	 than	parabss1	 [7].	 	The	 seizures	 in	
this	 mutant	 are	 due	 to	 a	 mutation	 in	 the	 Drosophila	 homolog	 of	 human	







I	wished	 to	 use	 this	 knowledge	 of	 bang‐sensitive	mutants	 to	 learn	more	 about	
genes	that	may	be	involved	in	seizure	susceptibility	when	mutated.		My	rationale	
for	this	 is	that	there	are	many	genes	that	may	have	not	yet	been	found	because	




excitability	 only	 in	 the	 presence	 of	 another	 mutation	 providing	 the	 seizure‐
susceptible	 background.	 	 	 Much	 work	 has	 been	 done	 using	 bang‐sensitive	
behavior	to	identify	seizure	suppressors	[16–18],	and	these	studies	usually	used	
the	homozygous	BS	mutation	 in	order	 to	screen	 for	suppressors.	 	To	screen	 for	




The	 rationale	 behind	 this	 particular	 screen	 was	 that	 a	 reduction	 of	 50%	 of	 a	
pathway	 component	 can	 result	 in	 enhancement	 or	 suppression	 of	 the	 mutant	
phenotype.		Although	this	was	a	very	successful	screen,	one	of	the	drawbacks	was	
the	time	and	effort	needed	to	map	the	mutations	created	by	EMS.		With	updated	
genetic	 tools	 available	 for	Drosophila	 research,	 such	 as	 libraries	 of	 deficiencies	
with	 carefully	 documented	 endpoints,	 as	 well	 as	 thousands	 of	 transposon	
insertion	 mutants	 and	 RNAi	 lines,	 screening	 and	 mapping	 can	 be	 done	 much	
more	efficiently.		In	order	to	understand	more	about	genes	that	may	affect	bang‐
sensitivity	 directly	 as	 well	 as	 increase	 our	 knowledge	 base	 of	 genes	 that	 can	
enhance	neuronal	 excitability	 as	a	heterozygous	mutation,	 I	 have	 conducted	an	
enhancer	screen	 in	a	heterozygous	bang‐sensitive	background	 to	 identify	genes	






All	 flies	were	 raised	 on	 standard	 yeast	 and	 glucose	media	 at	 25°C.	 	 I	 used	 the	
Exelixis	3R	deficiency	kit	 (Bloomington	Stock	Center)	 for	 the	deficiency	 screen.		
Several	seizure	mutants,	specifically	of	the	bang‐sensitive	class,	were	used	in	the	
heterozygous	 state	 as	 sensitized	 backgrounds	 for	 the	 screen.	 	 The	 three	 bang‐
sensitive	 lines	 I	used	 include	slamdance	 (sda),	paralyticbangsenseless1	 (parabss1),	and	
easily	shocked	 (eas),	and	were	a	gift	 from	Ronald	Hoy.	 	For	behavioral	controls,	
we	 crossed	 these	 bang‐sensitive	 lines	 to	w1118	 (#5905	 and	 #6326).	 	 Follow‐up	
crosses	to	the	screen	involved	deficiencies,	transposon	insertion	stocks,	or	RNAi	
stocks	 available	 from	 the	 Bloomington	 Stock	 Center.	 	 A	 complete	 list	 of	 stocks	
used	is	found	in	Table	B.1,	and	organized	in	greater	detail	in	Tables	B.5,	B.6,	and	




To	 test	 for	 bang‐sensitive	 paralysis,	 we	 performed	 testing	 similar	 to	 that	
previously	described	[7].		Briefly,	adult	flies	were	collected	1‐4	days	post	eclosion	





















deficiency	 kit	 and	 F1	 progeny	 were	 tested	 for	 seizure	 susceptibility	 upon	
vortexing.	 	 Those	 lines	 that	 had	 a	 large	 increase	 in	 paralysis	 after	 vortexing	








The	 deficiency	 screen	 for	 enhancers	 of	 bang‐sensitivity	 was	 done	 as	 follows:		
slamdance	 virgins	 were	 crossed	 to	 males	 of	 the	 Exelixis	 Df	 3R	 Kit	 and	 the	 F1	
progeny	were	 collected,	 sorted,	 and	 tested	 for	 the	penetrance	of	bang‐sensitive	
paralysis	as	described	above.		Deficiencies	that	caused	an	approximately	twofold	









Within	 the	 category	 of	 seizure‐susceptible	 Drosophila	 mutants,	 bang‐sensitive	
flies	 have	 a	 particularly	 robust	 phenotype	 in	 that	 they	 display	 a	 stereotyped	
seizure‐paralysis‐seizure	 phenotype	 upon	 being	 given	 a	 stimulus,	 such	 as	 a	
mechanical	impact	[20].		Heterozygotes	of	some	bang‐sensitive	mutants,	such	as	
sda	 and	parabss1	 are	 semi‐dominant	and	display	 a	 shorter	 seizure	and	paralysis	
phenotype	 at	 a	 lower	 penetrance	 than	 the	 homozygous	 mutant	 [7].	 	 We	 used	
these	 characteristics	 of	 heterozygous	 bang‐sensitive	 flies	 as	 a	 sensitized	
background	 in	 which	 to	 screen	 for	 genes	 that	 may	 be	 involved	 in	 neuronal	
excitability.	 	 Specifically,	 we	 crossed	 slamdance	 (sda)	 virgins	 to	 males	 of	 the	
Exelixis	 3R	 Deficiency	 Kit	 and	 tested	 progeny	 from	 these	 crosses	 for	 bang‐
sensitivity,	 focusing	 on	 the	 number	 of	 flies	 displaying	 paralysis	 after	 vortexing	
























"Enhancers"	 		 		 		 		 		
Df(3R)Exel6150		 7629	 23.1	 3.8	 74	 35	
Df(3R)Exel6151		 7630	 63.3	 10.4	 120	 2	
Df(3R)Exel6154		 7633	 50.8	 8.3	 59	 11	
Df(3R)Exel6161		 7640	 23.9	 3.9	 71	 15	
Df(3R)Exel6165		 7644	 60.0	 9.8	 60	 40	
Df(3R)Exel6178		 7657	 21.7	 3.6	 60	 48	
Df(3R)Exel6196		 7675	 43.3	 7.1	 60	 20	
Df(3R)Exel6270		 7737	 71.7	 11.7	 60	 23	
Df(3R)Exel7379		 7919	 36.5	 6.0	 63	 14	
Df(3R)Exel7317		 7932	 40.4	 6.6	 52	 17	
Df(3R)Exel7305		 7956	 35.0	 5.7	 60	 16	
Df(3R)Exel8157		 7973	 32.4	 5.3	 71	 9	
Df(3R)Exel7328		 7983	 23.3	 3.8	 60	 17	
Df(3R)Exel9013		 7991	 23.3	 3.8	 60	 15	
Df(3R)Exel9025		 7995	 23.3	 3.8	 60	 3	
Control	 		 		 		 		 		





other	 bang‐sensitive	 lines	 used	 because	 very	 few	 of	 the	 heterozygous	 sda	 flies	





138	 deletion	 lines	 [21]	 and	 we	 began	 the	 screening	 process	 with	 this	 set	 of	




Paralysis	 of	 20%	 of	 the	 flies	 tested	 represented	 a	 3.8	 times	 fold	 increase	 in	
paralysis	 compared	 to	 the	 sda/+	 control.	 	 Four	 of	 the	 19	 deficiencies	 were	
removed	 from	 the	 list	 since	 other	 deficiencies	 that	 were	 not	 enhancers	





bang‐sensitive	 lines,	 parabss1	 and	 eas.	 	 We	 hypothesized	 that	 some	 of	 these	
deficiencies	would	cause	enhancement	of	bang‐sensitivity	only	in	sda,	possibly	as	




resulted	 in	 seizure	 susceptibility	 relatively	 unchanged	 from	 that	 of	 control	
























Figure	 2.2	 	 Seizure	 penetrance	 enhancement	 by	 Exelixis	 deficiencies	 in	 three	











due	 to	 the	 higher	 penetrance	 of	 bang‐sensitivity	 in	 the	 parabss1/+	 background.		
eas,	on	the	other	hand,	 is	a	recessive	mutation	and	eas/+	females	are	not	bang‐
sensitive.	 	 Crossing	 eas	 to	 the	 18	 deficiencies	 produced	 no	 increase	 in	 bang‐





The	Exelixis	 deficiency	 library	 is	 suited	 for	 enhancer	 and	 suppressor	 screening	
due	 to	 each	 deficiency	 having	 well‐documented	 breakpoints	 and	 lists	 of	 genes	
deleted	within	the	deficiency	[21].		Once	we	determined	the	eighteen	deficiencies	
that	 enhanced	 bang‐sensitivity,	 we	 followed	 up	 first	 by	 searching	 for	 existing	
deficiencies	 that	 overlap	 the	 Exelixis	 deficiencies	 in	 order	 to	 narrow	down	 the	
window	of	candidate	genes.		These	follow‐up	deficiency	tests	are	summarized	in	




Exelixis	deficiencies	 to	 test	with	 sda.	 	We	 focused	on	genes	highly	expressed	 in	
the	brain	and	the	nervous	system	relative	to	 the	rest	of	 the	expression	pattern,	
either	in	larval	or	adult	stages.		These	genes	would	be	the	most	likely	candidates	
for	 direct	 involvement	 in	 neuronal	 excitability	 instead	 of	 resulting	 indirectly	
through	 other	 defects.	 	 We	 preferentially	 selected	 available	 null	 alleles	 of	 the	




For	 some	candidate	genes,	 instead	of	mutant	alleles,	we	obtained	RNAi	 lines	 to	














Figure	2.3	 	 Effects	 of	 transposon	 insertion	 alleles	 in	 enhancing	bang‐sensitivity	




these	 RNAi	 lines	 by	 crossing	 males	 to	 elav‐GAL4;	 sda	 females	 to	 cause	
panneuronal	knockdown	of	the	gene.	 	We	tested	the	F1	progeny	using	the	same	
behavioral	protocol	as	in	the	screen	and	used	elav‐GAL4/+;	sda/+	as	a	behavioral	
control	 (Figure	 2.4,	 Table	 B.7).	 	 In	 general,	 crosses	 with	 an	 elav‐GAL4;	 sda	
background	 tended	 to	 have	 lower	 seizure	 penetrance	 than	 crosses	 in	 a	 sda	
background	
	





In	 addition	 to	 deficiencies	 that	 enhanced	 seizure	 susceptibility,	 we	 found	 two	
Exelixis	deficiencies	 that	 showed	partial	 synthetic	 lethality	 in	 combination	with	
sda	but	not	with	parabss1	and	eas	(Table	2.3).		To	determine	the	genes	underlying	
the	 lethality,	 we	 obtained	 overlapping	 deficiencies	 and	 several	 alleles	 of	
candidate	genes	to	cross	and	test	for	viability.		The	cross	between	Exel6263	and	
sda	produced	very	few	flies	with	the	genotype	Exel6263/sda.	Three	overlapping	
deficiencies	 were	 tested	 and	 we	 were	 able	 to	 narrow	 down	 the	 window	 of	
candidate	genes	to	a	region	of	approximately	6	Mbp	containing	12	genes	(Table	
2.4,	Figure	B.2.		Candidate	genes	can	be	found	in	Table	B.8).	
The	 second	 deficiency,	 Exel6214,	 crossed	 to	 sda,	 produced	 a	 low	 number	 of	
Exel6214/sda	progeny	compared	to	the	balancer	siblings	(14/80	total)	instead	of	
the	 expected	 50%	 of	 the	 total	 progeny.	 	 We	 tested	 three	 genes	 within	 this	
deficiency	 with	 sda	 to	 see	 if	 any	 of	 these	 might	 be	 the	 cause	 of	 the	 partial	
lethality.		While	the	genes	tested	did	not	cause	lethality	(Table	B.9),	one	of	these,	
similar	 (sima),	 caused	a	 large	enhancement	 in	bang‐sensitivity	when	crossed	to	
elav‐GAL4;	 sda	 (Figure	 2.4).	 	 However,	 tests	 of	 a	 deficiency	 overlapping	 sima	
















Figure	 2.4	 	 Effects	 of	 neuron‐targeted	 RNAi	 knockdown	 in	 enhancing	 bang‐
sensitivity.		RNAi	targeted	to	all	neurons	by	crossing	elav‐GAL4;	sda	to	UAS‐RNAi	
constructs	 of	 putative	 sda	 enhancers.	 	 Data	 represented	 as	 fold	 change	 as	









was	 tested,	 our	 current	knowledge	of	 the	 extant	Drosophila	 seizure	 excitability	
mutants	 showed	 a	 wide	 array	 of	 genes	 with	 disparate	 functions	 and	 no	 clear	
relationship	between	those	with	very	similar	behavioral	phenotypes,	such	as	the	
BS	mutants	which	all	displayed	a	stereotypical	seizure‐paralysis	behavior	after	a	








Using	 sda	 as	 the	 sensitized	 seizure	 background,	 the	 Exelixis	 3R	 kit,	 and	
mechanically	 induced	seizures,	we	 found	19	Exelixis	deficiencies	 that	enhanced	
the	 BS	 phenotype	 of	 sda	 heterozygotes.	 	 With	 further	 testing	 using	 available	





directly	 associated	 with	 an	 ion	 channel.	 	 Though	 not	 much	 is	 known	 about	
CG9467,	the	gene	has	homology	to	the	human	epilepsy	gene	KCTD7	(potassium	
channel	 tetramerization	 domain‐containing),	 which	 functions	 in	 regulating	

















CG	No.	 Gene	name	 Function	 Biological	Processes	
Exel6151	 CG9755	 pumilio	(pum)	 translational	repressor	 synaptic	transmission	
dendrite	morphogenesis	
pole	cell	migration	
Exel6154		 CG9467	 		 oxidoreductase	activity	 oxidation‐reduction	
process	
potassium	ion	transport	
Exel6178		 CG14309	 		 unknown	 unknown	
Exel6196		 CG31140	 		 diacylglycerol	kinase	
activity	
lateral	inhibition	












































possible	 that	 many	 of	 these	 enhancer	 genes	 have	 a	 function	 in	 the	 nervous	






conductances	 in	motoneurons	of	sda	 larvae.	 	The	role	of	 the	aminopeptidase	 in	
causing	 this	 increase	of	Na+	 current	 is	 still	 unknown,	 though	 it	 is	hypothesized	
that	the	change	in	Na+	currents	and	ion	conductances	alters	neural	development	




One	 of	 the	 genes	 found	 in	 this	 screen,	 CG31140,	 is	 a	 diacylglycerol	 kinase	 that	
may	be	involved	in	neural	glial	development	through	lateral	inhibition.		This	gene	
is	 downregulated	 in	 the	 glial	 cells	missing	 mutant,	 where	 glia	 are	 transformed	
into	 neurons	 [27].	 	 Interestingly,	 this	 is	 the	 only	 gene	 from	 our	 screen	 that	
appears	 to	 enhance	 BS	 seizure	 in	 the	 sda	 heterozygote	 but	 not	 the	 parabss1	
heterozygote.		Tetraspanin	86D	(Tsp86D)	is	another	enhancer	found	in	the	screen.		
This	gene	encodes	a	 transmembrane	protein	expressed	throughout	 the	nervous	


















Exel6263/TM6B,	Tb	 Exel6263	 female	 0	 46	 35	
(#7730)	 		 male	 5	 49	 18	
		 TM6B,	Tb	 female	 43	 33	 23	
		 		 male	 37	 20	 21	
Exel6214/TM6B,	Tb	 Exel6124	 female	 11	 52	 53	
(#7692)	 		 male	 3	 42	 32	
		 TM6B,	Tb	 female	 38	 39	 50	
		 		 male	 29	 36	 21	
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Neurons	 are	 highly	 reliant	 on	 the	 secretory	 pathway	 for	 normal	 function.		
Packaging,	 transporting,	 and	 releasing	 neurotransmitters	 and	 peptides	 are	 all	
carefully	regulated	and	involve	many	components.		One	of	the	BS	enhancer	genes,	
yata,	 is	believed	 to	be	 involved	 in	 the	 sorting	of	vesicles	 in	 regulated	 secretory	
pathways,	such	as	those	needed	for	synaptic	transmission	[31].		Another	study	of	
yata	 suggests	 that	 it	 is	needed	 for	regulation	of	protein	 localization,	specifically	
the	 amyloid	 precursor‐like	 (APPL)	 protein	 in	 Drosophila	 [32].	 	 Another	 BS	
enhancer	 and	 secretory	 pathway	 gene,	 Sorting	 nexin	 3	 (Snx3),	 is	 a	 protein	
expressed	in	cytoplasm	and	is	a	part	of	the	retrograde	transport	from	endosomes	





Sima	 is	 the	Drosophila	version	of	mammalian	hypoxia	 inducible	 factor	α	 (HIF‐α)	
and	is	regulated	by	oxygen	levels	by	a	protein	domain	that	functions	as	an	oxygen	
sensor	[34].		The	normal	function	of	Sima	is	to	detect	hypoxia,	which	leads	to	the	







and	 as	 a	 neurotransmitter,	 and	 is	 reported	 to	 have	 a	 connection	 with	 human	






















Df(3R)Exel6263	 7730	 84E6‐‐84E13	 Lethal	
Df(3R)BSC196	 9200	 84E6‐‐84E11	 Lethal	
Df(3R)BSC196	 9622	 84E6‐‐84E8	 Lethal	
Df(3R)BSC222	 9699	 84E8‐‐84F6	 Viable	
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gycβ	 along	with	 α	 subunits	 regulates	 2nd	messenger	 pathways	 that	 result	 from	
the	presence	of	NO	due	to	neural	activity	or	stressors	[38].		Work	has	shown	that	




Translational	 control	 is	 essential	 for	 gene	 regulation	 during	 all	 stages	 of	
development,	 often	 through	 mechanisms	 such	 as	 polyadenylation	 and	
deadenylation,	 recruiting	 4E	 binding	 proteins,	 repression	 by	 microRNAs,	 and	
ribosomal	 binding	 regulation	 (reviewed	 in	 [40]).	 	 Studies	 in	 Drosophila,	 C.	
elegans,	 and	 Xenopus	 have	 shown	 that	 translational	 control	 is	 required	 for	
oogenesis	 and	 early	 development	 [41],	 [42].	 	 However,	 evidence	 suggests	 that	
translational	 control	 is	 connected	 to	 neuronal	 excitability	 as	 well,	 such	 as	 in	
regulating	neural	development	(reviewed	in	[43]).		Therefore,	it	is	not	surprising	
that	several	of	the	genes,	specifically	Akt,	pumilio	(pum),	and	CG18616,	found	in	
this	 screen	 are	 involved	 in	 translational	 control.	 	 Akt	 is	 a	 part	 of	 a	 pathway	
responsible	for	elF2α	phosphorylation	in	response	to	stress.		The	end	product	of	
this	 pathway	 is	 the	 inhibition	 of	 mRNA	 translation	 [44].	 	 CG18616	 is	 a	
transcription	 factor	 that	 is	 the	 fly	homolog	of	human	NOT10,	which	 is	a	part	of	
the	 carbon	 catabolite‐repression	 4‐NOT	 (CCR4‐NOT)	 complex	 involved	 in	
deadenylation	of	mRNA	[45].	 	Though	not	much	is	known	about	CG18616	itself,	
the	CCR4‐NOT	complex	is	suggested	to	be	a	“chaperone	platform”	present	in	most	




increase	neuronal	excitability.	 	Pum	 is	a	 translational	 repressor	best	known	 for	
its	 function	 in	 early	 development	 where	 it	 is	 implicated	 in	 maintenance	 of	
germline	 stem	 cells	 and	 establishing	 the	 anterior‐posterior	 axis	 through	
regulating	expression	of	hunchback	[47],	[48].		More	recent	work	has	shown	that	
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pum	 regulates	 neuronal	 excitability.	 	 Specifically,	 Pum	 is	 involved	 in	 the	
formation	of	higher	order	dendrites	[49].		This	function	in	dendritogenesis	is	also	
supported	 by	 evidence	 from	 the	 mammalian	 homolog	 of	 pum,	 Pumilio2	 [50].		
Another	 study	 showed	 that	 levels	 of	 pum	 mRNA	 is	 regulated	 by	 amounts	 of	
neuronal	 activity,	 and	 that	 lowering	 levels	 of	 Pum	 itself	 increased	 the	 mRNA	
levels	 of	 a	 voltage‐gated	Na+	 channel	 [51].	 	 Therefore,	 it	was	 not	 surprising	 to	
identify	pum	 as	 an	 enhancer	 of	 seizure	 behavior.	 	 It	 is	 interesting	 to	 note	 that	








susceptibility	using	a	BS	mutant	as	 the	sensitized	background.	 	We	expected	 to	
find	 both	 general	 enhancers	 of	 seizure	 as	 well	 as	 possible	 interactors	 of	 the	
neural	membrane	aminopeptidase	encoded	by	sda	[14].		Through	this	screen,	we	
identified	12	known	genes,	excluding	pum,	that	were	previously	not	connected	to	
any	 phenotype	 related	 to	 enhancing	 neuronal	 excitability	 or	 seizures.	 	 The	
deficiency	 screening	 method	 allowed	 for	 relatively	 quick	 forward	 genetic	
screening	 of	 specific	 regions	 of	 the	 genome	 followed	 up	 by	 a	 reverse	 genetics	
approach	of	determining	if	mutations	of	specific	genes	can	increase	BS	behavior.		
Enhancer	screens	typically	 identify	components	of	pathways	[54]	but	the	genes	
we	 identified	may	 not	 be	 specific	 enhancers	 of	 sda	 as	 they	 enhanced	multiple	
bang‐sensitive	 lines,	 though	 further	 testing	 is	 needed	 to	 confirm	 this.	 	 One	
interesting	result	is	the	finding	of	two	deficiencies	that	appear	to	be	semi‐lethal	
in	 combination	 with	 sda.	 	 Though	 the	 identity	 of	 the	 genes	 that	 cause	 this	




Although	 this	 screen	 only	 covered	 65%	 of	 chromosome	 3R,	 we	 believe	 this	
method	can	be	effectively	extended	to	encompass	most	of	the	Drosophila	genome	
since	 the	 combination	 of	 Bloomington	 Deficiency	 Project,	 Exelixis,	 and	 the	
DrosDel	 deficiency	 collections	 together	 cover	 between	 94‐98.9%	 of	 genes	 on	
each	 chromosome.	 	 The	 initial	 stage	 of	 the	 screen	 is	 quick	 and	 efficient	 due	 to	
needing	only	 one	 generation	of	 crosses,	 the	 follow‐up	 stages	 can	be	more	 time	
consuming	 since	 a	 large	 collections	 of	 stocks	 need	 to	 be	 obtained	 for	 the	
subsequent	 testing.	 	 This	was	 one	 of	 the	 reasons	 that	 our	 search	 for	 enhancer	
genes	was	 biased	 towards	 those	with	 neuronal	 expression,	 in	 order	 to	 narrow	
down	our	search	pool	of	genes	as	much	as	possible.			
	
One	note	 to	make	about	 this	 screening	method	 is	 that	many	of	 the	deficiencies	
that	 were	 found	 to	 enhance	 BS	 phenotype	 penetrance	 gave	 a	 much	 higher	
percentage	of	 flies	 seizing	 than	did	 any	of	 the	 individual	 enhancer	 genes.	 	 This	
can	 be	 due	 to	 the	 deficiency	 causing	 an	 entire	 deletion	 of	 the	 gene,	 while	 the	
alleles	could	be	hypomorphs,	but	this	can	also	be	due	to	multiple	genes	within	the	
deficiency	 that	 contributing	 to	 the	 BS	 phenotype.	 	 For	 example,	 alleles	 of	 pum	
never	enhanced	the	BS	phenotype	as	much	as	the	Exelixis	deficiency	containing	
pum.	 	 However,	 the	 deficiency	 also	 contained	 two	 other	 genes	 that	 slightly	
enhanced	 the	 seizure	 penetrance,	 and	 it	 may	 be	 possible	 that	 these	 genes	 in	
combination	 with	 pum	 allowed	 the	 Exelixis	 deficiency	 to	 give	 a	 stronger	




In	 summary,	 in	 this	 work	 we	 screened	 for	 genes,	 which	 when	 mutated	 or	
knocked	down,	enhance	the	penetrance	of	the	BS	seizure	phenotype.		The	genes	
found	 in	 this	 work	 encode	 a	 range	 of	 different	 products	 such	 as	 kinases,	
transcription	 factors,	 and	 translational	 repressors,	 among	others.	 	 Though	 they	
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mostly	have	unrelated	 functions,	 their	effects	on	enhancing	bang‐sensitivity	are	
almost	 identical,	 varying	 only	 in	 the	 actual	 magnitude	 of	 seizure	 penetrance.		
Most	 of	 these	 genes	 enhanced	 at	 least	 two	 BS	 lines,	 indicating	 that	 they	 may	
contribute	 to	a	general	 increase	 in	bang	sensitivity,	 though	one	gene,	CG31440,	
has	 a	 specific	 effect	 on	 sda.	 	 Since	 our	 screen	 generally	 focused	 on	 genes	 that	
were	 expressed	 at	 moderate	 to	 high	 levels	 (according	 to	 FlyAtlas	 Anatomical	
Expression	 Data)	 in	 the	 nervous	 system,	 a	 large	 number	 of	 the	 genes	 we	
identified	 as	 enhancers	 have	 known	 roles	 in	 the	 nervous	 system,	 though	 none	
have	 been	 directly	 implicated	 in	 seizure	 behavior	 or	 increases	 in	 neuronal	
excitability.		Further	work	on	these	genes	alongside	the	BS	mutants	may	help	us	


































































































































































































3.1  Abstract 
The gene pumilio (pum) encodes a translational repressor well known in Drosophila 
development to regulate anterior-posterior patterning and germ line maintenance.  
More recent work has implicated this gene in later stages of development, specifically 
in the nervous system, to regulate processes such as expression of ion channels and 
dendrite arborization.  Studies in other organisms also support the function of pum in 
neuronal development and excitability.  We discovered that pum is also able to 
enhance seizure susceptibility in a sensitized background when mutated, and therefore 
we have used this phenotype to learn more about the timing and location of Pum 
function with relation to neural development.  Using behavioral tests, 
electrophysiology, and immunohistochemistry, we show that the effect of pum 
mutation on neuronal excitability is greatest when there is a reduction of Pum levels in 
cholinergic and GABAergic neurons, in comparison to other types of neurons, and that 
this reduction is required at multiple stages of development. 
 
3.2  Introduction 




in	 Drosophila	 and	 C.	 elegans	 [2].	 	 	 However,	 increasing	 evidence	 reveals	 the	
importance	of	translational	control	in	the	normal	development	and	functioning	of	
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the	 nervous	 system	 [3],	 [4]	 by	 providing	 a	 means	 of	 post‐transcriptionally	
regulating	 gene	 expression	 to	 specific	 locations	 where	 the	 translation	 of	 the	
mRNA	 is	needed.	 	 Since	neurons	are	specialized	cells	and	highly	polarized,	 it	 is	
essential	 that	gene	expression	 is	 regulated	at	 specific	 sites	of	 the	cell	 to	ensure	
proper	development.		Also,	since	neurons	are	compartmentalized	and	often	have	
axons	and	dendrites	that	may	extend	away	from	the	cell	body,	regulating	mRNAs	
already	 present	 in	 these	 structures	 provides	 a	 fast	method	 of	 controlling	 gene	
expression,	instead	of	using	de	novo	mRNA	synthesis	[5],	[6].	
	





functions,	and	has	been	well	characterized	 in	early	stages	of	 the	Drosophila	 life	
cycle,	 including	 establishment	 of	 the	 anterior‐posterior	 axis,	 abdominal	
segmentation	 [12],	 and	maintenance	 of	 germline	 stem	 cells	 [13].	 	 Early	 on,	 the	
main	 focus	 of	 pum	 research	 was	 on	 its	 role	 regulating	 embryonic	 anterior‐
posterior	axis	 formation	 through	several	genes	such	as	hunchback.	 	However,	a	
new	mutant,	 named	 bemused,	 was	 found	 as	 a	 behavioral	mutant	with	 reduced	
coordination	and	flight	ability	[14]	and	was	eventually	discovered	to	be	an	allele	




made	 to	 discover	 its	 targets	 and	 gain	 a	 more	 thorough	 understanding	 of	 its	
functions	 [16],	 [17].	 	 Pum	 is	 believed	 to	 have	 a	 wide	 range	 of	 targets	 for	




in	 vivo	 assays	 [17].	 	 A	 screen	 searching	 for	 genes	 involved	 in	 learning	 and	
memory,	by	both	mutagenesis	and	microarray,	revealed	the	gene	pum	as	well	as	
staufen,	a	gene	which	has	a	Pum	binding	sequence	in	its	mRNA,	suggesting	Pum’s	
role	 in	 synaptic	modification	 [18].	 	 More	 evidence	 for	 this	 came	 from	 another	
study	 showing	 that	 the	 translational	 control	by	Pum	does	 indeed	play	a	 role	 in	
synaptic	 modification,	 specifically	 in	 the	 elaboration	 of	 higher	 order	 dendrites	
[19].	 	This	was	 followed	up	by	work	on	pum	 in	 the	mouse	model	 showing	 that	
microRNAs	regulate	levels	of	Pum	in	order	to	control	dendritogenesis	[20].			
	
More	 direct	 evidence	 that	pum	 is	 involved	 in	 synaptic	 transmission	 came	 from	
another	study	when	the	pum	allele,	pumbemused,	crossed	into	a	seizure‐susceptible	
background	 showed	 that	 levels	 of	 pum	mRNA	 itself	 are	 regulated	 by	 neuronal	
activity.	 	 Reduction	 in	 Pum	 resulted	 in	 an	 increase	 of	 paralytic	 (para)	 mRNA,	
which	 encodes	 a	 voltage‐gated	 Na+	 channel.	 Likewise,	 overexpression	 of	 Pum	
caused	 reduction	 in	 the	 magnitude	 of	 the	 Na+	 current	 in	 motoneurons	 [21].		
However,	 while	 there	 is	 evidence	 connecting	 pum	 to	 functions	 in	 synaptic	
transmission	 and	 neuronal	 excitability,	 its	 expression	 pattern	 in	 the	 adult	
nervous	 system,	 the	 effects	 of	 pum	 mutations	 on	 the	 behavior	 of	 seizure‐
susceptible	 mutants,	 and	 the	 importance	 of	 Pum	 in	 specific	 stages	 of	
development	for	normal	neuronal	excitability	remains	unknown.	
	
To	 better	 understand	 the	 role	 of	 pum	 in	 regulating	 neuronal	 excitability,	 we	




allele	 is	 heterozygous.	 	We	 show	 that	 this	 seizure	 behavior	 increase	 correlates	
with	 a	 lowering	 of	 the	 voltage	 of	 the	 stimulus	 required	 to	 directly	 induce	 a	
seizure.	 	 In	 analyzing	 the	 expression	 pattern	 of	 Pum,	 we	 found	 that	 all	 cells	
positive	for	Pum	also	are	positive	for	neural	markers,	indicating	that	the	protein	
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is	 present	 only	 in	 neurons.	 	 Panneural	 knockdown	of	 Pum	using	RNAi	 reduces	
most	of	 its	expression	 in	 the	brain.	 	Targeted	knockdown	of	Pum	specifically	 in	
cholinergic	 and	 GABAergic	 neurons	 produces	 a	 strong	 increase	 in	 seizure	
behavior	as	well.		Finally	we	show	that	reduction	of	Pum	in	both	larval	and	adult	
stages	is	needed	in	order	for	the	increase	in	BS	seizure	behavior	to	be	apparent.		





Flies	 were	 maintained	 on	 standard	 yeast	 and	 glucose	 media	 at	 25°C.	 	 Bang‐
sensitive	 stocks	 slamdance,	 easily	 shocked,	 and	 parabangsenseless	 were	 a	 gift	 from	
Ronald	 Hoy.	 	 Except	 when	 mentioned,	 all	 other	 stocks	 are	 available	 from	 the	
Drosophila	 Stock	 Center	 (accompanied	 by	 stock	 number).	 	 w1118	 (#5905	 and	
#6326)	 crossed	 to	 bang‐sensitive	 stocks	 were	 used	 as	 a	 behavioral	 control.		
Deficiencies	 used	 that	 affect	 pumilio	 include,	Df(3R)by10,	 red1	 e1/TM3,	 Sb1	 Ser1	
(#1931),	 w1118;	 Df(3R)Exel6151,	 P{w+mC=XP‐U}Exel6151/TM6B,	 Tb1	 (#7630),	
w1118;	 Df(3R)Exel6152,	 P{w+mC=XP‐U}Exel6152/TM6B,	 Tb1	 (#7631),	 and	 w1118;	




In	 tests	 using	 knockdown	 of	 pumilio,	we	 crossed	 a	 pum‐RNAi	 line	 (pum‐RNAi,	
#101399,	 Vienna	 Drosophila	 RNAi	 Center)	 to	 various	 GAL4	 lines.	 	 For	 tests	
requiring	overexpression	of	pumilio,	we	crossed	UAS‐pum	(gift	of	Michael	Stern)	
to	 various	 GAL4	 lines.	 	 For	 specific	 temporal	 control	 of	 pumilio	 RNAi,	 we	
recombined	 pum‐RNAi	 with	 a	 Gal80ts	 line,	 w*;	 P{w+mC=tubP‐GAL80ts}10;	




















GAL4	 lines	 used	 include	 promoters	 of	 the	 following	 genes:	 Choline	
acetyltransferase	 (cha)	 (w1118;	 P{w+mC=Cha‐GAL4.7.4}19B/CyO,	
P{ry+t7.2=sevRas1.V12}FK1)	 (#6798)	 and	 Vesicular	 acetylcholine	 transporter	
(VAChT)	 (w1118;	 P{GMR55G09‐GAL4}attP2)	 (#46075)	 to	 target	 cholinergic	
neurons,	vesicular	glutamate	 transporter	 (P{w+mC=VGlut‐GAL4.D}1,	w*)	 (#24635)	
to	target	glutamatergic	neurons,	reversed	polarity	(w1118;	P{w+m*=GAL4}repo/TM3,	
Sb1)	 (#7415)	 to	 target	 glia,	 β	 amyloid	 protein	 precursor‐like	 (P{w+m*=Appl‐
GAL4.G1a}1,	 y1	 w*)	 (#32040)	 to	 target	 neurons,	 tyrosine	 decarboxylase	 (w*;	
P{w+mC=Tdc2‐GAL4.C}2)	(#9313)	to	target	octopaminergic	neurons,	Actin	 (y1	w*;	
P{Act5C‐GAL4‐w}E1/CyO)	 (#25374)	 to	 target	 all	 cells,	 slit	 (w*;	 P{w+mC=GAL4‐
sli.S}3)	 (#9580)	 to	 target	midline	 glia,	elav	 (P{w+mW.hs=GawB}elavC155)	 (#458)	 to	








temperature.	 	The	 larvae	were	 incubated	 in	primary	antibody	overnight	at	4°C,	
then	washed	again	in	PBST	three	times	quickly	and	three	times	15	minutes.		After	
this,	 the	 larvae	were	 put	 in	 secondary	 antibody	 in	 PBST	 +	 10%	donkey	 serum	
incubation	for	four	hours	at	room	temperature,	and	then	washed	again	in	PBST	




Paul	 MacDonald),	 anti‐elav	 (mouse,	 1:100,	 Developmental	 Studies	 Hybridoma	
Bank),	anti‐βgal	(mouse,	1:200,	Promega),	anti‐GFP	(rabbit,	1:2000,	 Invitrogen).		













Figure	 3.2	 	 Seizure	 threshold	 in	 bang‐sensitive	 heterozygotes	 reduced	 by	













paraformaldehyde	 solution	 for	 20	minutes.	 	 The	brains	were	 briefly	washed	 in	
PBS	 and	 then	 quickly	 rinsed	 three	 times	 and	 15	minutes	 three	 times	 in	 PBST.		
Brains	were	then	blocked	in	PBST	+	10%	donkey	serum	for	one	hour	and	placed	
in	 primary	 antibody	 overnight	 at	 4°C.	 	 The	 brains	were	 given	 three	 quick	 and	
three	15	minute	washes	in	PBST	and	placed	in	secondary	antibody	overnight	at	
4°C.		The	brains	were	washed	overnight	in	wash	solution,	after	which	they	were	




The	primary	 antibodies	 used	 are	 as	 follows:	 anti‐pumilio	B	 (rat,	 1:1000,	 gift	 of	
Paul	 Macdonald),	 anti	 elav	 (mouse,	 1:200,	 Developmental	 Studies	 Hybridoma	
Bank),	anti‐bruchpilot	 (mouse,	1:100,	Developmental	Studies	Hybridoma	Bank),	
anti‐GFP	 (rabbit,	 1:2000,	 Invitrogen),	 and	 anti‐βgal	 (mouse,	 1:200,	 Promega).		
Secondary	 antibodies	 are	 as	 follows:	 	 goat	 anti‐rat	 488	 (Invitrogen),	 goat	 anti‐
rabbit	 488	 (Invitrogen),	 donkey	 anti‐mouse	 Cy3	 (#715‐165‐151,	 Jackson	












[22].	 	 Adult	 flies	 2‐5	days	 post	 eclosion	were	 sorted	 into	 vials	 the	day	prior	 to	
recording	and	allowed	 to	recover.	 	Flies	were	 individually	handled	without	CO2	
anesthesia	using	a	modified	Tetra	Whisper	100	aquarium	pump	and	mounted	on	
dental	wax	on	 a	 glass	 slide,	 leaving	 the	dorsal	 surface	of	 the	 fly	 exposed.	 	 Two	
electrodes	 were	 inserted	 into	 the	 head	 underneath	 the	 antennae,	 a	 recording	
electrode	 inserted	 into	 the	 thorax,	 and	 the	neutral	 electrode	 into	 the	abdomen.		
The	 stimulating	 electrode	 was	 connected	 to	 the	 Grass	 S48	 Stimulator	 (Grass	
Instruments),	and	the	recording	electrodes	to	the	differential	AC	amplifier	(Model	
1700,	 A‐M	 Systems)	 to	 the	 oscilloscope	 (TDS1002B,	 Tektronix).	 	 All	 electrodes	






All	 confocal	 imaging	 was	 done	 using	 on	 the	 Leica	 SP2	 at	 the	 Cornell	 Imaging	
Facility.	 	 Images	were	taken	using	either	the	40x	oil	 immersion	lens	and	20x	or	
63x	 water	 immersion	 lens	 at	 1x	 or	 2x	 zoom.	 	 All	 images	 were	 cropped	 using	


















pum.	 	 parabss1	 flies	 were	 crossed	 to	 various	 pum	 alleles	 and	 tested	 for	 seizure	
after	vortexing.	 	The	threshold	parabss1/+;	pum01688/+	 is	significantly	 lower	than	









In	 a	 previous	 mutant	 screen,	 we	 searched	 for	 deficiencies	 that	 increased	 the	
occurrence	 of	 seizures	 in	 a	 sensitized	 seizure‐susceptible	 background.	 	 This	
screen	was	performed	in	the	slamdance	(sda)	background,	which	is	a	member	of	
the	 group	 of	Drosophila	 seizure	mutants	 known	 as	 bang‐sensitives,	 due	 to	 the	
phenotype	 of	 displaying	 strong	 seizures	 after	 being	 given	 a	 mechanical	 or	
electrical	stimulus.		One	of	the	deficiencies	found	in	this	screen	with	the	strongest	
effects	 on	 increasing	 seizure	 penetrance	 in	 sda	 heterozygotes	 was	 the	 Exelixis	
deficiency	 Exel6151.	 	 Further	 behavior	 testing	 showed	 that	 this	 deficiency	
enhanced	 bang‐sensitivity	 in	 two	 other	 bang	 sensitive	 lines,	paralyticbangsenseless1	
(parabss1)	and	easily	shocked	(eas)	(Figure	3.1).		To	confirm	that	this	enhancement	
in	 bang‐sensitivity	 has	 a	 neuronal	 basis,	 we	 used	 electrophysiology	 to	 test	
threshold	 of	 the	 voltage	 stimulus	 given	 to	 the	 fly	 brain	 to	 induce	 a	 seizure.	 	 In	
both	 the	 parabss1	 and	 sda	 backgrounds,	 the	 presence	 of	 Exel6151	 significantly	
reduced	 the	 seizure	 threshold	 compared	 to	 parabss1/+	 and	 sda/+	 controls	
(p<0.05)	(Figure	3.2).	
	
Since	 the	 deficiencies	within	 the	 Exelixis	 collection	 are	well	 characterized	 and	
have	 defined	 breakpoints,	 we	 knew	 that	 there	 are	 four	 genes	 deleted	 within	
Exel6151,	three	of	which	are	moderately	to	highly	expressed	in	neural	tissue.		In	
the	 screen,	we	 targeted	 genes	 that	 are	 highly	 expressed	 in	 the	 nervous	 system	
since	 these	 would	 be	 most	 likely	 to	 have	 a	 direct	 effect	 on	 enhancing	 seizure	
susceptibility.		Therefore,	we	obtained	transposon	insertions	for	the	three	genes	
and	 crossed	 these	 to	 sda.	 	 The	progeny,	which	were	heterozygous	 for	 both	 the	
transposon	 and	 sda,	 were	 tested	 for	 bang‐sensitivity.	 	 The	 progeny	 tested	 are	
heterozygous	 for	 both	 the	 transposon	 and	 sda.	 	 Of	 the	 three	 genes	 tested,	 the	
gene	pumilio	(pum)	was	the	most	effective	at	enhancing	bang‐sensitivity,	though	


























Figure	 3.6	 	 Expression	 of	 pumilio	 in	 adult	 brains.	 	 Confocal	 images	 of	 pumilio	







(Figure	 3.3).	 	 Electrophysiology	 tests	 of	 these	 various	pum	 alleles	 showed	 that	
there	 is	 a	 significant	 decrease	 in	 seizure	 threshold	 in	 parabss1/+;	 pum01688	






adults	 since	 most	 immunohistochemistry	 for	 Pum	 has	 previously	 been	 done	
mainly	 in	 embryos	 and	 adult	 reproductive	 organs	 [23],	 but	 not	 in	many	 other	







brains	with	 pum	and	 elav	 antibodies	 and	observed	 that	pum	 staining	 occurred	
only	 in	 neuron	 cell	 bodies	 (Fig	 3.6).	 	 We	 also	 double	 stained	 with	 Pum	 and	
Bruchpilot	(Brp),	a	synaptic	marker,	to	show	that	pum	is	located	in	the	cell	bodies	
and	not	 in	 the	neuropil	 (Figure	C.1).	 	Double	staining	with	a	glial	marker,	 repo,	




Since	 we	 observed	 that	 Pum	 is	 expressed	 in	 neurons,	 we	 hypothesized	 that	
targeted	knockdown	of	Pum	in	neurons	or	subsets	of	neurons	using	RNAi	could	











after	 vortexing	 compared	 to	 control	 (parabss1/+).	 	 Pumilio	 is	 knocked	 down	 by	
RNAi	using	specific	GAL4	drivers	in	a	sda	background.		Elav	=	panneural,	VAChT	=	
cholinergic	 neuron,	 cha	 =	 cholinergic	 neurons,	 appl	 =	 panneural,	 tdc	 =	
octopaminergic	 neurons,	 gad1	 =	 GABA‐ergic	 neurons,	 repo	 =	 glia,	 vglut	 =	
glutamatergic	neurons,	slit	=	glia.		N≥20	for	each	genotype.	
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pum	 transposon	 alleles	 and	 deletions.	 	We	 tested	 this	 hypothesis	 in	 two	 bang‐
sensitive	backgrounds	by	crossing	either	parabss1;	pum‐RNAi	or	pum‐RNAi;	sda	to	
various	 GAL4	 lines	 that	 target	 the	 nervous	 system.	 	 The	 candidate	 GAL4	 lines	
targeted	 cholinergic	 neurons,	 Choline	 acetyltransferase	 (Cha)	 and	 Vesicular	
acetylcholine	 transporter	 (VAChT),	 octopaminergic	 neurons,	 tyrosine	









larval	 brain	 (Figure	 C.4).	 	 The	 results	 are	 similar	 in	 the	 adult	 brain,	 where	
knockdown	 of	 Pum	 results	 in	 an	 almost	 complete	 lack	 of	 Pum	 staining	 in	 the	
brain	 and	 thoracic	 abdominal	 ganglion	 (Figure	 3.11).	 	 This	 reduction	 of	 Pum	
staining	is	apparently	only	when	we	use	elav‐GAL4	as	the	driver,	since	when	we	








as	 cholinergic	 neuron	 drivers	 (Cha	 and	 VAChT)	 caused	 a	 twofold	 or	 higher	
increase	 in	 bang‐sensitivity	 in	 the	 tested	 adults	 (Figure	 3.7,	 Table	 C.1).	 	 We	
expected	 that	 since	 pum	 alleles	 are	 able	 to	 enhance	 seizure	 susceptibility	 in	











in	 GABA‐ergic	 neurons	 by	 Gad2B‐GAL4,	 and	 to	 a	 lesser	 extent	 in	 cholinergic	















parabss1;	 pum‐RNAi	 flies	 were	 crossed	 to	 panneural	 driver	 elav‐GAL4	 and	 the	




effective	 in	 enhancing	 seizure	 penetrance	 in	 other	 BS	 mutants.	 	 When	 we	
repeated	this	experiment	by	crossing	pum‐RNAi;	sda	to	the	different	drivers,	we	




To	 confirm	 that	 the	 increase	 in	 bang‐sensitivity	 penetrance	 was	 due	 to	 an	
increase	 in	 neuronal	 excitability,	 we	 measured	 the	 seizure	 threshold	 of	 the	
parabss1,	 elav‐GAL4/+;	 pum‐RNAi/+	 flies,	 which	 had	 given	 the	 strongest	
enhancement	 phenotype	 in	 the	 vortex	 testing.	 	 We	 found	 that	 the	 seizure	
threshold	 for	 this	genotype	 is	 significantly	 lower	 in	parabss1,	elav‐GAL4/+;	pum‐








cholinergic	 neuron	 driver	 VAChT‐GAL4	 was	 also	 effective	 at	 increasing	 the	
penetrance	 of	 bang‐sensitivity	 in	 the	parabss1	 and	 sda	 backgrounds	 (Figure	 3.8,	
Figure	 3.9).	 	 One	 possibility	 for	 this	 phenotype	 is	 that	 cholinergic	 neurons	
comprise	a	large	subset	of	the	cells	stained	by	Pum,	so	we	used	antibody	staining	
to	determine	the	pattern	of	VAChT‐positive	cells	compared	to	Pum‐positive	cells.		
We	 constructed	 an	 nls‐GFP;	VAChT‐GAL4	 stock	 to	 express	 GFP	 in	 the	 nuclei	 of	
cells	 that	 express	VAChT	 and	 performed	double	 antibody	 staining	 against	 Pum	
and	GFP	in	these	flies.		In	third	instar	larvae,	we	observed	in	the	ventral	ganglion,	































3.4.4	 Disruption	 of	 pumilio	 expression	 during	 the	 entire	 life	 cycle	 causes	
enhancement	of	neuronal	excitability	




specific	 stages	 of	 the	 fly	 life	 cycle.	 	We	 crossed	 this	 line	 to	 elav‐GAL4,	 sda	 and	
raised	 the	progeny	at	 the	 restrictive	 temperature	during	specific	periods	of	 the	
life	 cycle.	 	 GAL4	 is	 active	 only	 at	 the	 restrictive	 temperature,	 so	 knockdown	of	
Pum	occurs	only	during	this	time.	 	 In	this	 initial	 test,	all	eggs	were	laid	at	25°C.		
One	set	of	flies	was	placed	at	29°C	during	all	larval	stages,	another	set	was	placed	
at	29°C	from	pupation	to	adulthood,	and	another	set	of	flies	were	raised	at	29°C	
from	the	 first	 instar	stage	and	onwards.	 	We	collected	the	 flies	and	tested	them	
for	bang‐sensitivity,	and	observed	that	only	flies	raised	for	their	entire	life	cycle	
at	 the	 restrictive	 temperature	 showed	 a	 large	 increase	 in	 seizure	 penetrance	
(Figure	3.14).		Those	raised	at	the	restrictive	temperature	through	pupation	and	



















Figure	 3.12	 	 Localization	 of	 Pum	 in	 cholinergic	 neurons	 in	 third	 instar	 larval	
brains.	 	 Anti‐GFP	 and	 anti‐Pum	 staining	 with	 VAChT‐GAL4	 driving	 a	 nuclear	
localized	 GFP	 in	 the	 larval	 brain,	 specifically	 the	 lobe	 (A‐C)	 and	 the	 ventral	
ganglion	(D‐F).		Scale	bar	is	100	μm.		
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RNAi	using	a	panneural	driver	was	able	 to	abolish	much	of	 the	Pum	staining	 in	
both	 larval	 and	 adult	 brains.	 	 Knockdown	 of	 Pum	 using	 drivers	 that	 targeted	
subsets	of	neurons	did	not	noticeably	remove	Pum	staining.		One	explanation	for	
this	 is	 that	 different	 GAL4	 drivers	 have	 different	 levels	 of	 effectiveness.	 	 For	
example,	 we	 used	 two	 different	 elav‐GAL4	 lines	 (C155	 and	 3A4)	 in	 our	
experiments,	 and	C155	had	a	much	 stronger	 effect	 on	expression	and	behavior	




throughout	 the	 central	 nervous	 system,	 especially	 in	 the	 Kenyon	 cells	 of	 the	
mushroom	 bodies	 [18].	 	 We	 did	 observe	 increased	 staining	 ventral	 to	 the	
mushroom	bodies,	between	the	antennal	lobes	and	mushroom	bodies.		However,	




in	 neuroblasts	 or	 earlier	 stages,	 but	 does	 appear	 in	 all	 neurons,	 a	 possible	
explanation	 may	 be	 that	 these	 cells	 are	 in	 the	 process	 of	 differentiating	 into	
neurons.		While	cell	division	and	differentiation	in	the	adult	brain	is	rare,	recent	
work	 has	 shown	 that	 there	 is	 indeed	 cell	 proliferation	 in	 the	 adult	 fly	 brain.		
These	cells	are	also	located	around	the	area	of	the	antennal	lobe	[26].	
	
From	 a	 deficiency	 screen,	 we	 identified	 pum	 as	 an	 enhancer	 of	 bang‐sensitive	
behavior.	 	 The	 deficiency	 that	 deleted	 pum	 was	 able	 to	 enhance	 the	 seizure	
penetrance	 in	 three	different	bang‐sensitive	mutants,	parabss1,	 sda,	 and	eas	 that	
are	 known	 to	 have	 different	 seizure	 thresholds	 but	 cause	 very	 similar	 seizure‐
paralysis‐seizure	 phenotypes	 [27].	 	 parabss1	 is	 a	 gain‐of‐function	 mutation	 in	 a	
voltage‐gated	 Na+	 channel	 that	 causes	 a	 change	 in	 Na+	 inactivation	 [28].	 	 sda	
























seizures	 through	 different	 methods,	 the	 enhancement	 of	 seizure	 penetrance	
caused	by	pum	 is	most	 likely	 due	 to	 a	 general	 increase	 in	neuronal	 excitability	
instead	of	being	specific	 to	a	defect	caused	by	one	bang‐sensitive	mutant.	 	Flies	
that	are	mutant	for	pum	do	not	have	seizures	themselves.		However,	recent	work	
in	 mice	 has	 shown	 that	 those	 carrying	 a	 specific	 allele	 of	 pum2,	 the	 mouse	
homolog	of	Drosophila	pum,	show	spontaneous	seizures	due	to	handling	and	have	
lower	 seizure	 thresholds	 in	 response	 to	 convulsants	 [31].	 	 This	 suggests	 that	





neurons.	 	 Studies	 using	 pumbem,	 an	 allele	 of	 pum,	 showed	 that	 Pum	 is	 able	 to	
regulate	 Na+	 current	 in	 specific	 motoneurons,	 and	 the	 pumbem	 allele	 is	 able	 to	
increase	 Na+	 current	 which	 would	 lead	 to	 greater	 neuronal	 excitability	 [21].		
Therefore,	 it	 had	 been	 believed	 that	 the	 primary	 cause	 of	 increased	 neuronal	
excitability	due	to	pum	mutations	is	due	to	defects	in	motor	neurons.	 	However,	
we	 found	 that	 knockdown	 of	 Pum	 in	 glutamatergic	 neurons,	 which	 releases	
glutamate	at	the	neuromuscular	 junction	(NMJ),	 in	a	parabss1	or	sda	background	
did	not	enhance	bang‐sensitivity	as	much	as	other	types	of	neurons.		Instead,	the	
neurons	 that	 produced	 the	 greatest	 effect	 on	BS	 behavior	were	 the	 cholinergic	
neurons	 in	 the	 case	 of	 the	 parabss1/+	 background.	 	 A	 previous	 study	 on	 the	
vesicular	 acetylcholinergic	 transporter	 (VAChT)	 showed	 the	 defects	 in	 VAChT	
caused	 defects	 in	 the	 giant	 fiber	 pathway,	 most	 likely	 due	 to	 reduction	 in	
acetylcholine	 levels	 at	 the	giant	 fiber	 synapses	 [32].	 	 Studies	 in	mice	 show	 that	
VAChT	 knockouts	 have	 spontaneous	 release	 of	 neurotransmitters	 at	 the	



















possible	 that	pum	 has	 a	 role	 in	 normal	 development	 of	 the	 NMJ	 in	 cholinergic	









(kcc)	mutant	 [34],	 [35].	 	Analysis	 of	 the	kcc	mutant	 suggested	 that	 influence	of	





seizure	behavior	 is	 limited	 to	 sda,	we	hope	 to	 explore	 the	 role	of	 sda	 in	neural	
development	during	these	pupal	stages.	
	
We	 have	 shown	 in	 this	 study	 that	 mutations	 of	 pum	 in	 flies	 cause	 a	 strong	
enhancement	in	BS	seizures.	 	Since	Pum	is	expressed	in	neurons,	knockdown	of	
Pum	 using	 neural	 drivers	 also	 replicates	 this	 effect,	 though	 most	 potently	 by	
panneural	 drivers,	 and	 almost	 as	 well	 by	 cholinergic,	 and	 GABAergic	 neuron	
drivers.	 	 Conditional	 knockdown	of	 Pum	during	 specific	 stages	 of	 development	
showed	 that	 a	 reduction	 of	 Pum	must	 occur	 both	 in	 larval	 and	 through	 pupal	
stages	 in	 order	 for	 the	 seizure	 enhancement	 to	 occur.	 	 Also,	 there	 is	 a	 period	
between	third	 instar	and	pupal	stages	that	 is	 important	 for	development.	 	With	
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In	 the	previous	chapters,	 I	have	discussed	a	behavioral	genetic	screen	 in	which	
we	 looked	 for	 genes	 that	may	 help	 our	 understanding	 of	 neuronal	 excitability,	
and	 by	 extension,	 the	 underlying	 mechanisms	 and	 genetics	 behind	
epileptogenesis.	 	 Following	 this,	 I	 discussed	 our	 analysis	 of	 one	 of	 the	 genes,	
pumilio	(pum)	that	was	found	in	this	screen.			
	
4.2	 	 	 Deficiency	 screening	 for	 enhancers	 of	 the	 bang‐sensitive	 mutant	
slamdance	
Since	research	 in	 the	genetic	basis	of	epilepsy	 is	moving	 towards	 large	scale	or	
genome	wide	studies	to	identify	genes	associated	with	epilepsy	[1],	we	hoped	to	
use	 the	 tools	 available	 to	Drosophila	 to	 efficiently	 screen	 for	 such	 genes	 in	 fly	
seizure	mutants.	 	The	goal	of	this	project	was	to	find	new	genes,	previously	not	





We	 screened	 chromosome	 3R	 for	 enhancers	 of	 seizure	 susceptibility	 using	 an	
Exelixis	deficiency	kit.		Out	of	the	15	Exelixis	deficiencies	that	enhanced	the	bang‐
sensitivity	of	 sda	 heterozygotes	we	discovered	11	 candidate	 genes	with	known	
functions.		Three	of	the	eleven	genes	are	known	to	be	involved	in	nervous	system	
development:	Tetraspanin	86D	(Tsp86D),	CG31140,	and	48	related	2	(fer2).		Two	
have	 functions	 in	 the	secretory	pathway:	yata	 and	Sorting	nexin	3	 (Snx3).	 	Two	
encode	O2	and	NO	sensors.		Guanylyl	cyclase	β	encodes	an	NO	sensor	and	Similar	









by	 testing	 the	Exelixis	deficiencies	 that	 contained	 these	genes	 and	 showing	 the	
general	 enhancement	 to	 both	 BS	 mutants.	 	 One	 of	 the	 genes	 causes	 seizure	
enhancement	 specific	 to	 sda	 and	may	 encode	 a	product	 that	 is	 an	 interactor	of	





4.3	 	 pumilio	 is	 required	 during	 several	 development	 stages	 for	 normal	
neuronal	excitability	
We	 explored	 the	 role	 of	 pum	 in	 enhancing	 seizure	 susceptibility	 after	 it	 was	
discovered	in	the	deficiency	screen.		Though	other	work	had	shown	that	pum	was	
involved	 in	neuronal	excitability	and	growth	of	 the	neuromuscular	 junction	[2],		
[3],	they	did	not	show	an	actual	change	in	behavior.		We	showed	in	chapter	3	that	




We	 were	 able	 to	 show	 by	 using	 Pum	 and	 elav	 antibody	 staining	 that	 Pum	 is	
expressed	 in	most	 if	 not	 all	 neurons.	 	We	 also	 showed	 that	 Pum	 expression	 is	
predominantly	 in	 neurons,	 as	 knocking	 down	 Pum	 using	 RNAi	 targeted	 to	
neurons	 abolishes	 most	 Pum	 expression.	 	 This	 allowed	 us	 to	 perform	 further	
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studies	using	elav‐GAL4	 to	 study	 the	effects	of	 conditional	Pum	knockdowns	at	
specific	points	in	the	life	cycle.			
	
4.3.2	 	 Decreasing	 levels	 of	 Pum	 through	 mutant	 alleles	 or	 RNAi	 knockdown	
enhances	bang‐sensitive	behavior	
Mutations	 in	pum	 can	 cause	enhancement	of	BS	 seizure	penetrance	 in	both	 the	




seizure	 response	 is	 significantly	 lower	 than	 in	 control	 flies.	 	 These	 results	
provided	behavioral	evidence	 that	pum	 is	 involved	 in	seizure	susceptibility	and	







We	 tested	 Pum	knockdown	 in	 various	 subsets	 of	 neurons	 to	 determine	 if	 Pum	
function	 in	 neuronal	 excitability	 is	 limited	 to	 specific	 neurons.	 	We	 discovered	
that	 in	both	parabss1	 and	 sda,	 knockdown	of	Pum	 in	cholinergic	neurons	caused	
enhancement	 of	 BS	 seizures.	 	 In	 the	 sda	 background,	 knockdown	 of	 Pum	 in	
GABAergic	neurons	had	an	even	greater	effect	on	 seizure	behavior.	 	This	 is	 the	
first	 example	 showing	 that	 Pum	 expression	 in	 specifically	 cholinergic	 and	
GABAergic	neurons	is	needed	for	normal	neuronal	excitability.	
	
4.3.4	 	Enhancement	 of	BS	 phenotype	 only	 occurs	when	 there	 is	 Pum	 knockdown	
through	larval	and	pupal	stages	
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We	 initially	 thought	 that	 since	seizure	behavior	 is	only	apparent	 in	adult	bang‐











As	with	most	genetic	screens,	 the	screen	 itself	 is	only	the	very	beginning	of	 the	
project.	 	 Our	 screen	 and	 subsequent	 study	 of	 pum	 leaves	 us	 with	 other	 9	
candidate	enhancer	genes	of	neuronal	excitability.	 	The	next	 steps	would	be	an	
analysis	of	each	of	these	genes	similar	to	what	we	have	done	for	pum.		We	would	
need	 to	ascertain	where	 these	genes	are	expressed,	what	developmental	 stages	





the	 screen	 was	 successful	 for	 discovering	 enhancer	 genes,	 a	 more	 expansive	












must	 take	place	over	 this	 entire	period,	 if	 there	 is	 one	 time	period,	 or	multiple	
developmental	 stages.	 	 Further	 testing	 can	 help	 us	 to	 figure	 these	 critical	
developmental	 stages,	 and	 this	 knowledge	 can	 subsequently	 be	 used	 to	 test	
specific	 neuronal	 subsets,	 such	 as	 cholinergic	 and	 GABAergic	 neurons.	 	 Since	
these	represent	a	population	of	excitatory	neurons	and	a	population	of	inhibitory	
neurons,	 respectively,	 it	 is	 possible	 that	 Pum	 functions	 through	more	 than	 one	
mechanism	or	pathway	in	order	to	cause	the	enhancement	of	BS	behavior.	
	
Pum	 most	 likely	 regulates	 a	 large	 number	 of	 genes,	 as	 revealed	 by	 a	 screen	
mRNAs	with	Pum	binding	sequences[4],	 though	a	screen	 for	synaptic	 targets	of	
Pum	 only	 resulted	 in	 a	 small	 number	 of	 genes	 [5].	 	 It	 is	 possible	 that	 some	 of	
these	 synaptic	 targets	 of	 Pum	 also	 regulate	 neuronal	 excitability,	 and	 that	
behavior	 testing	 using	 the	 same	methods	 as	 described	 in	 the	 deficiency	 screen	




It	 is	our	belief	 that	 that	 this	work	will	 contribute	 to	 the	 role	of	Drosophila	 as	 a	
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Exelixis	Number	 Stock	Number	 %	paralyzed	 Fold	change	 #	tested	
Df(3R)Exel6140		 7619	 5.4	 0.9	 74	
Df(3R)Exel6141		 7620	 0.0	 0.0	 60	
Df(3R)Exel6142		 7621	 0.0	 0.0	 60	
Df(3R)Exel6143		 7622	 0.0	 0.0	 68	
Df(3R)Exel6144		 7623	 13.3	 2.2	 60	
Df(3R)Exel6145		 7624	 11.7	 1.9	 60	
Df(3R)Exel6146		 7625	 8.0	 1.3	 50	
Df(3R)Exel6147		 7626	 7.7	 1.2	 65	
Df(3R)Exel6148		 7627	 0.0	 0.0	 95	
Df(3R)Exel6149		 7628	 0.0	 0.0	 67	
Df(3R)Exel6150		 7629	 23.1	 3.7	 52	
Df(3R)Exel6151		 7630	 63.3	 10.2	 120	
Df(3R)Exel6152		 7631	 0.0	 0.0	 60	
Df(3R)Exel6153		 7632	 0.0	 0.0	 82	
Df(3R)Exel6154		 7633	 50.8	 8.2	 59	
Df(3R)Exel6155		 7634	 10.0	 1.6	 60	
Df(3R)Exel6156		 7635	 1.7	 0.3	 60	
Df(3R)Exel6157		 7636	 11.7	 1.9	 60	
Df(3R)Exel6158		 7637	 12.0	 1.9	 75	
Df(3R)Exel6159		 7638	 15.8	 2.5	 76	
Df(3R)Exel6160		 7639	 11.7	 1.9	 60	
Df(3R)Exel6161		 7640	 23.9	 3.9	 71	
Df(3R)Exel6162		 7641	 1.6	 0.3	 64	
Df(3R)Exel6163		 7642	 5.2	 0.8	 58	
Df(3R)Exel6164		 7643	 8.3	 1.3	 60	
Df(3R)Exel6165		 7644	 60.0	 9.7	 60	
Df(3R)Exel6166		 7645	 3.3	 0.5	 60	
Df(3R)Exel6167		 7646	 20.0	 3.2	 60	
Df(3R)Exel6168		 7647	 0.0	 0.0	 72	
Df(3R)Exel6169		 7648	 0.0	 0.0	 60	
Df(3R)Exel6170		 7649	 1.7	 0.3	 60	
Df(3R)Exel6171		 7650	 0.0	 0.0	 75	
Df(3R)Exel6172		 7651	 20.0	 3.2	 60	
Df(3R)Exel6173		 7652	 3.2	 0.5	 62	
Df(3R)Exel6174		 7653	 1.4	 0.2	 69	
Df(3R)Exel6176		 7655	 0.0	 0.0	 67	
Df(3R)Exel6178		 7657	 21.7	 3.5	 60	
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Exelixis	Number	 Stock	Number	 %	paralyzed	 Fold	change	 #	tested	
Df(3R)Exel6179		 7658	 2.3	 0.4	 88	
Df(3R)Exel6180		 7659	 0.0	 0.0	 66	
Df(3R)Exel6181		 7660	 20.0	 3.2	 60	
Df(3R)Exel6182		 7661	 0.0	 0.0	 57	
Df(3R)Exel6184		 7663	 0.0	 0.0	 60	
Df(3R)Exel6185		 7664	 0.0	 0.0	 60	
Df(3R)Exel6186		 7665	 0.0	 0.0	 60	
Df(3R)Exel6187		 7666	 1.0	 0.2	 98	
Df(3R)Exel6188		 7667	 0.0	 0.0	 60	
Df(3R)Exel6189		 7668	 14.9	 2.4	 67	
Df(3R)Exel6190		 7669	 5.5	 0.9	 55	
Df(3R)Exel6191		 7670	 9.1	 1.5	 77	
Df(3R)Exel6192		 7671	 0.0	 0.0	 60	
Df(3R)Exel6193		 7672	 6.7	 1.1	 60	
Df(3R)Exel6194		 7673	 1.7	 0.3	 60	
Df(3R)Exel6195		 7674	 0.0	 0.0	 69	
Df(3R)Exel6196		 7675	 43.3	 7.0	 60	
Df(3R)Exel6197		 7676	 3.6	 0.6	 56	
Df(3R)Exel6198		 7677	 0.0	 0.0	 60	
Df(3R)Exel6199		 7678	 0.0	 0.0	 60	
Df(3R)Exel6200		 7679	 0.0	 0.0	 60	
Df(3R)Exel6201		 7680	 0.0	 0.0	 54	
Df(3R)Exel6202		 7681	 5.0	 0.8	 60	
Df(3R)Exel6203		 7682	 18.3	 3.0	 60	
Df(3R)Exel6204		 7683	 8.3	 1.3	 60	
Df(3R)Exel6205		 7684	 33.3	 5.4	 51	
Df(3R)Exel6206		 7685	 9.4	 1.5	 64	
Df(3R)Exel6208		 7686	 15.0	 2.4	 60	
Df(3R)Exel6209		 7687	 0.0	 0.0	 60	
Df(3R)Exel6210		 7688	 0.0	 0.0	 65	
Df(3R)Exel6211		 7689	 3.3	 0.5	 60	
Df(3R)Exel6212		 7690	 5.1	 0.8	 59	
Df(3R)Exel6213		 7691	 0.0	 0.0	 92	
Df(3R)Exel6214		 7692	 0.0	 0.0	 19	
Df(3R)Exel6215		 7693	 0.0	 0.0	 60	
Df(3R)Exel6216		 7694	 0.0	 0.0	 82	
Df(3R)Exel6217		 7695	 11.7	 1.9	 60	
Df(3R)Exel6218		 7696	 1.5	 0.2	 65	
Df(3R)Exel6259		 7726	 0.0	 0.0	 65	
Df(3R)Exel6263		 7730	 0.0	 0.0	 1	
Df(3R)Exel6264		 7731	 0.0	 0.0	 60	
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Exelixis	Number	 Stock	Number	 %	paralyzed	 Fold	change	 #	tested	
Df(3R)Exel6265		 7732	 11.7	 1.9	 60	
Df(3R)Exel6267		 7734	 3.3	 0.5	 60	
Df(3R)Exel6269		 7736	 0.0	 0.0	 60	
Df(3R)Exel6270		 7737	 71.7	 11.6	 60	
Df(3R)Exel6273		 7740	 0.0	 0.0	 53	
Df(3R)Exel6274		 7741	 2.9	 0.5	 69	
Df(3R)Exel6275		 7742	 3.3	 0.5	 60	
Df(3R)Exel6276		 7743	 3.4	 0.5	 59	
Df(3R)Exel6280		 7746	 0.0	 0.0	 60	
Df(3R)Exel6288		 7752	 0.0	 0.0	 60	
Df(3R)Exel9020		 7917	 3.4	 0.5	 59	
Df(3R)Exel8194		 7918	 18.3	 3.0	 60	
Df(3R)Exel7379		 7919	 36.5	 5.9	 63	
Df(3R)Exel7315		 7931	 15.5	 2.5	 58	
Df(3R)Exel7317		 7932	 40.4	 6.5	 52	
Df(3R)Exel7357		 7948	 0.0	 0.0	 60	
Df(3R)Exel9029		 7951	 0.0	 0.0	 60	
Df(3R)Exel7283		 7952	 0.0	 0.0	 78	
Df(3R)Exel7284		 7953	 3.3	 0.5	 60	
Df(3R)Exel8143		 7954	 1.7	 0.3	 60	
Df(3R)Exel9036		 7955	 16.7	 2.7	 60	
Df(3R)Exel7305		 7956	 35.0	 5.6	 60	
Df(3R)Exel7306		 7957	 1.7	 0.3	 60	
Df(3R)Exel8152		 7958	 5.0	 0.8	 60	
Df(3R)Exel7308		 7959	 0.0	 0.0	 60	
Df(3R)Exel7309		 7960	 0.0	 0.0	 60	
Df(3R)Exel8154		 7961	 13.3	 2.2	 60	
Df(3R)Exel9018		 7962	 21.7	 3.5	 60	
Df(3R)Exel8153		 7963	 5.0	 0.8	 60	
Df(3R)Exel9019		 7964	 6.7	 1.1	 60	
Df(3R)Exel7310		 7965	 1.7	 0.3	 60	
Df(3R)Exel7312		 7966	 33.3	 5.4	 60	
Df(3R)Exel8155		 7967	 0.0	 0.0	 60	
Df(3R)Exel7313		 7968	 10.0	 1.6	 80	
Df(3R)Exel7314		 7969	 0.0	 0.0	 53	
Df(3R)Exel7316		 7970	 5.4	 0.9	 74	
Df(3R)Exel7318		 7972	 5.0	 0.8	 60	
Df(3R)Exel8157		 7973	 32.4	 5.2	 71	
Df(3R)Exel8158		 7974	 11.7	 1.9	 60	
Df(3R)Exel7320		 7975	 13.2	 2.1	 53	
Df(3R)Exel8159		 7976	 0.0	 0.0	 52	
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Exelixis	Number	 Stock	Number	 %	paralyzed	 Fold	change	 #	tested	
Df(3R)Exel7321		 7977	 16.7	 2.7	 60	
Df(3R)Exel7326		 7980	 0.0	 0.0	 60	
Df(3R)Exel8162		 7981	 2.8	 0.4	 72	
Df(3R)Exel7327		 7982	 5.7	 0.9	 70	
Df(3R)Exel7329		 7984	 0.0	 0.0	 57	
Df(3R)Exel7330		 7985	 3.3	 0.5	 60	
Df(3R)Exel8163		 7987	 1.6	 0.3	 64	
Df(3R)Exel8165		 7988	 0.0	 0.0	 60	
Df(3R)Exel9030		 7989	 28.3	 4.6	 60	
Df(3R)Exel9012		 7990	 0.0	 0.0	 60	
Df(3R)Exel9013		 7991	 23.3	 3.8	 60	
Df(3R)Exel9014		 7992	 10.0	 1.6	 70	
Df(3R)Exel8178		 7993	 3.3	 0.5	 60	
Df(3R)Exel9056		 7994	 3.0	 0.5	 99	
Df(3R)Exel9025		 7995	 23.3	 3.8	 60	























Df(3R)Exel6150		 7629	 40.0	 1.0	 60	
Df(3R)Exel6151		 7630	 95.9	 2.5	 73	
Df(3R)Exel6154		 7633	 69.8	 1.8	 53	
Df(3R)Exel6161		 7640	 68.3	 1.8	 60	
Df(3R)Exel6165		 7644	 38.7	 1.0	 75	
Df(3R)Exel6178		 7657	 71.2	 1.8	 73	
Df(3R)Exel6196		 7675	 45.2	 1.2	 73	
Df(3R)Exel6270		 7737	 76.7	 2.0	 60	
Df(3R)Exel7305		 7956	 95.0	 2.4	 60	
Df(3R)Exel7317		 7932	 96.2	 2.5	 52	
Df(3R)Exel7328		 7983	 98.5	 2.5	 68	
Df(3R)Exel7379		 7919	 85.0	 2.2	 60	
Df(3R)Exel8157		 7973	 100.0	 2.6	 58	
Df(3R)Exel9013		 7991	 44.9	 1.1	 49	
Df(3R)Exel9025		 7995	 81.1	 2.1	 53	
control	 		 		 		 		



















Df(3R)Exel6150	 7629	 0	 58	
Df(3R)Exel6151	 7630	 11.5	 52	
Df(3R)Exel6154	 7633	 0.0	 80	
Df(3R)Exel6161	 7640	 0.0	 87	
Df(3R)Exel6165	 7644	 0.0	 67	
Df(3R)Exel6178	 7657	 0.0	 76	
Df(3R)Exel6196	 7675	 0.0	 53	
Df(3R)Exel6270	 7737	 2.2	 89	
Df(3R)Exel7305	 7956	 0.0	 64	
Df(3R)Exel7317	 7932	 0.0	 63	
Df(3R)Exel7328	 7983	 0.0	 61	
Df(3R)Exel7379	 7919	 0.0	 59	
Df(3R)Exel8157	 7973	 0.0	 62	
Df(3R)Exel9013	 7991	 0.0	 51	
Df(3R)Exel9025	 7995	 0.0	 53	
control	 		 		 		


















7661	 Df(3R)Exel6182	 0.0	 0.0	 60	
7731	 	Df(3R)Exel6264	 2.5	 0.2	 40	
7969	 Df(3R)Exel7314	 10.4	 0.9	 48	
8968	 Df(3R)ED5516	 2.5	 0.2	 40	
9086	 Df(3R)ED5591	 16.7	 1.5	 60	
9206	 Df(3R)ED5573	 16.7	 1.5	 24	
9225	 Df(3R)ED5301	 5.0	 0.4	 60	
9227	 Df(3R)ED5428	 20.5	 1.8	 44	
9338	 Df(3R)ED5296	 7.7	 0.7	 26	
9482	 Df(3R)ED10642	 33.3	 3.0	 60	
9699	 Df(3R)BSC222	 27.4	 2.4	 62	
24976	 Df(3R)BSC472	 0.0	 0.0	 60	
24981	 Df(3R)BSC477	 13.9	 1.2	 36	
24994	 Df(3R)BSC490	 13.8	 1.2	 29	
25006	 Df(3R)BSC502	 8.9	 0.8	 45	
25013	 Df(3R)BSC509	 41.7	 3.7	 60	
25057	 Df(3R)BSC529	 0.0	 0.0	 60	
25126	 Df(3R)BSC568	 36.7	 3.3	 60	
25740	 Df(3R)BSC650	 0.0	 0.0	 86	
26534	 Df(3R)BSC682	 6.7	 0.6	 60	
26580	 Df(3R)BSC728	 3.3	 0.3	 60	
26838	 Df(3R)BSC740	 9.4	 0.8	 53	
27363	 Df(3R)BSC791	 20.0	 1.8	 60	

















Figure	 B.1	 	 Bang‐sensitivity	 testing	 of	 sda	 crossed	 to	 deficiencies	 overlapping	

















Gene	 Associated	Exel	Df	 %	Paralyzed	 Fold	Difference	 Number	Tested	
w1118	 5905	 6.1	 1	 180	
Akt	 7983	 35.0	 5.7	 20	
CG10324	 7737	 0.0	 0.0	 34	
CG11140	 7675	 63.8	 10.4	 80	
CG14309	 7657	 16.3	 2.7	 80	
CG18005	 7630	 15.0	 2.5	 60	
CG31140	 7675	 18.3	 3.0	 60	
CG5903	 7983	 0.0	 0.0	 20	
CG5916	 7983	 3.8	 0.6	 80	
CG6574	 7956	 1.7	 0.3	 60	
CtBP	 7973	 11.3	 1.8	 80	
Fas1	 7737	 0.0	 0.0	 60	
Glut4ef	 7633	 17.5	 2.9	 80	
GycBeta	 7919	 36.7	 6.0	 60	
Hug	 7932	 11.7	 1.9	 60	
kdm2	 7630	 13.3	 2.2	 60	
Koko	 7657	 10.0	 1.6	 80	
Mcm5	 7638	 11.7	 1.9	 60	
nonA‐1	 7737	 11.4	 1.9	 70	
Pros	 7962	 0.0	 0.0	 60	
Pum	 7630	 8.8	 1.4	 80	




















control	 2.5	 1	 80	
AdoR	 7692	 12.5	 5	 80	
Art1	 7956	 7.0	 2.8	 100	
ATPsyngamma	 7995	 1.4	 0.6	 69	
ccty	 7737	 0.0	 0	 17	
CG18549	 7932	 0.0	 0	 100	
CG18616	 7932	 7.7	 3.1	 13	
CG3747	 7730	 5.0	 2	 100	
CG42342	 7737	 15.0	 6	 80	
CG4596	 7956	 6.3	 2.5	 80	
CG9467	 7633	 10.0	 4	 80	
CtBP	 7973	 0.0	 0	 80	
fbx011	 7633	 1.3	 0.5	 80	
fer2	 7983	 16.3	 6.5	 80	
GycBeta	 7919	 13.8	 5.5	 80	
hug	 7932	 4.0	 1.6	 100	
npf	 7737	 5.0	 2	 100	
sima	 7692	 31.3	 12.5	 80	
Tsp86D	 7956	 10.0	 4	 80	





















































































Exelixis	Deficiency	 Gene Type Stock	Number	 Fold	Change
Df(3R)Exel6151	 7630 10.4
Df(3R)ED5296 Deficiency 9338 1.3
Kdm2	 P‐element 30819 2.2
CG18995 P‐element 15965 2.5
pum	 P‐element 21042 3.3
pum	 P‐element 11544 3.7
Df(3R)Exel6154		 		 7633 8.3
Teh1	 P‐element 13221 0.0
Glut4ef P‐element 16364 2.9
CG9467 RNAi 26724 4.0
fbx011 RNAi 31484 0.5
Df(3R)Exel6178		 		 7657 3.6
Df(3R)BSC650 Deficiency 25740 0.0
Df(3R)BSC682 Deficiency 26534 1.1
Df(3R)BSC509 Deficiency 25013 6.8
repo	 P‐element 11604 0.2
koko	 P‐element 21214 1.6
CG14309 P‐element 31839 2.7
Df(3R)Exel6196		 		 7675 7.1
Df(3R)Exel9014 Deficiency 7992 1.6
CG31140 P‐element 23750 3.0
CG11140 P‐element 13427 10.5
Df(3R)Exel6270		 		 7737 11.7
Df(3R)BSC472 Deficiency 24976 0.0
Df(3R)ED10642 Deficiency 9482 5.5
Fas1	 P‐element 16029 0.0
npf	RNAi RNAi 27237 0.8
nonA‐1 P‐element 16690 1.9
CG10324 P‐element 19012 0.0
CG42342 RNAi 28628 6.0
ccty	 P‐element 34969 0.0
Df(3R)Exel7379		 		 7919 6.0
GycB	 P‐element 15221 6.0
GycB	 RNAi 28786 5.5
Df(3R)Exel7317		 7932 6.6
Df(3R)BSC847 Deficiency 27920 0.3
Df(3R)ED5573 Deficiency 9206 2.7
hug	 RNAi 28705 1.6
hug	 P‐element 23491 1.9
CG18616 RNAi 32957 3.1
CG18549 RNAi 34391 0.0
Df(3R)Exel7305		 		 7956 5.7
 104 
Df(3R)BSC529 Deficiency 25057 0.0
Df(3R)BSC568 Deficiency 25126 6.0
Art1	 RNAi 31348 1.1
CG6574 P‐element 17837 0.3
Tsp86D RNAi 28515 4.0
CG4596 RNAi 28617 2.5
Df(3R)Exel7328		 		 7983 3.8
Df(3R)Exel7327 Deficiency 7982 0.9
Df(3R)BSC728 Deficiency 26580 0.3
Akt	 P‐element 11627 5.7
CG5903 P‐element 20714 0.0
CG5916 P‐element 31803 0.6
fer2	 RNAi 28697 6.5
Df(3R)Exel9025		 		 7995 3.8
ATPsyngamma RNAi 28723 0.6






















		 Df(3R)BSC477	 Deficiency	 24981	 2.3	
Df(3R)Exel6161		 		 		 7640	 3.9	
Deficiency	 8968	 0.4	
Deficiency	 7743	 0.6	
Df(3R)Exel6165		 		 		 7644	 9.8	
Df(3R)BSC740	 Deficiency	 26838	 1.5	
		 Df(3R)ED5591	 Deficiency	 9086	 2.7	
Df(3R)Exel8157		 		 7973	 5.3	
CtBP	 Transposon	 11590	 1.6	
CtBP	 RNAi	 31334	 0.0	
Df(3R)Exel9013		 		 		 7991	 3.8	
Df(3R)BSC490	 Deficiency	 24994	 2.3	

























































































































parabss1/+	;	pum‐RNAi/+	 control	 72	 155	 46.5	 1.0	
	
parabss1/elav‐GAL4;	pum‐
RNAi/+	 panneuronal	 50	 50	 100.0	 2.2	
	
parabss1/appl	–GAL4;	
pum‐RNAi/+	 panneuronal	 88	 96	 91.7	 2.0	
	
parabss1/+	;	pum‐
RNAi/tdc2	 octopaminergic	neurons	 16	 21	 76.2	 1.6	
	
parabss1/vglut	–GAL4;	
pum‐RNAi/+	 glutamatergic	neurons	 14	 28	 50.0	 1.1	
	
parabss1/+	;	VaCHT‐
GAL4/pum‐RNAi	 cholinergic	neurons	 20	 21	 95.2	 2.1	
	
parabss1/+	;	cha‐
GAL4/pum‐RNAi	 cholinergic	neurons	 65	 71	 91.5	 2.0	
	
parabss1/+	;	slit‐GAL4/+;	
pum‐RNAi/+	 glia	 11	 33	 33.3	 0.7	
	
parabss1/+		;	repo‐
GAL4/+;	pum‐RNAi/+	 glia	 22	 40	 55.0	 1.2	
	
parabss1/+	;	gad1‐






















pum‐RNAi/+;	sda/+	 control	 80	 4	 5.0	 1.0	
	
elav‐GAL4,	pum‐RNAi/+;	
sda/+	 panneural	 80	 65	 81.3	 16.3	
	
Gad2B/pum‐RNAi;	sda/+	 GABAergic	neurons	 80	 63	 78.8	 15.8	
pum‐RNAi/VAChT‐GAL4;	










neurons	 80	 17	 21.3	 4.3	
	
pum‐RNAi/+;	sda/slit‐
GAL4	 glia	 80	 10	 12.5	 2.5	
	
pum‐RNAi/cha‐GAL4;	






























































1	 First	Instar	 100.0	 100.0	
2	 96.9	 97.4	
3	 Second	Instar	 100.0	 100.0	
4	 100.0	 100.0	





8	 Pupa	 64.7	 100.0	
10	 		 95.8	 100.0	
	
 
 
